<SEC-DOCUMENT>0001144204-19-017990.txt : 20190403
<SEC-HEADER>0001144204-19-017990.hdr.sgml : 20190403
<ACCEPTANCE-DATETIME>20190403153056
ACCESSION NUMBER:		0001144204-19-017990
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190516
FILED AS OF DATE:		20190403
DATE AS OF CHANGE:		20190403
EFFECTIVENESS DATE:		20190403

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celcuity Inc.
		CENTRAL INDEX KEY:			0001603454
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38207
		FILM NUMBER:		19728812

	BUSINESS ADDRESS:	
		STREET 1:		16305 36TH AVENUE N
		STREET 2:		SUITE 450
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55446
		BUSINESS PHONE:		763-392-0767

	MAIL ADDRESS:	
		STREET 1:		16305 36TH AVENUE N
		STREET 2:		SUITE 450
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55446

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Celcuity LLC
		DATE OF NAME CHANGE:	20140324
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tv516969_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proxy Statement Pursuant to Section 14(a)
(Rule 14a-101) of the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by the Registrant <FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by a Party other than the Registrant <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Preliminary Proxy Statement</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><B>Confidential, for Use of the Commission Only (as permitted
by Rule 14a-6(e)(2))</B></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">x</FONT></TD><TD STYLE="text-align: justify">Definitive Proxy Statement</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Definitive Additional Materials</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Soliciting Material Pursuant to &sect;240.14a-12</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Celcuity
Inc.</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Registrant as Specified in its
Charter)</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s) Filing Proxy Statement,
if Other Than the Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment of Filing Fee (Check the appropriate box):</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">x</FONT></TD><TD STYLE="text-align: justify">No fee required.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Fee computed on table below per Exchange Act Rules 14a-6(i)(4)
and 0-11.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">(1)</TD>
    <TD>Title of each class of securities to which transaction applies:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(2)</TD>
    <TD>Aggregate number of securities to which transaction applies:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(3)</TD>
    <TD>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(4)</TD>
    <TD>Proposed maximum aggregate value of transaction:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(5)</TD>
    <TD>Total fee paid:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Fee paid previously with preliminary materials.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD>Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and
the date of its filing.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">(1)</TD>
    <TD>Amount Previously Paid:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(2)</TD>
    <TD>Form, Schedule or Registration Statement No.:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(3)</TD>
    <TD>Filing Party:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(4)</TD>
    <TD>Date Filed: </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Celcuity
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-align: center">16305 36th Avenue North, Suite
100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-align: center">Minneapolis, MN 55446</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-align: center"><B>NOTICE OF ANNUAL MEETING OF
STOCKHOLDERS<BR>
TO BE HELD ON MAY 16, 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>TO THE STOCKHOLDERS OF CELCUITY INC.:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps">Please
Take Notice</FONT> that Celcuity Inc. (&ldquo;Celcuity&rdquo;) will hold its 2019 Annual Meeting of Stockholders at the offices
of Celcuity Inc., 16305 36th Avenue North, Suite 100, Minneapolis, MN 55446, on May 16, 2019 at 2:00 p.m. local time. Celcuity
is holding this meeting for the purpose of considering and taking appropriate action with respect to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-indent: -0.3in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: left">To elect the five director nominees named in the Proxy
Statement to the Celcuity Board of Directors, to serve until the earlier of the next annual meeting of stockholders, the election
of such director&rsquo;s successor, or such director&rsquo;s death, resignation or removal;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-indent: -0.3in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: left">To ratify the appointment of Boulay PLLP as Celcuity&rsquo;s
independent registered public accounting firm for the year ending December 31, 2019;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-indent: -0.3in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">To approve, on an advisory basis, named executive officer
compensation; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-indent: -0.3in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: left">To transact any other business as may properly come
before the meeting or any adjournments thereof, including matters incident to the conduct of the meeting.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of record of
Celcuity common stock at the close of business on March 18, 2019 will be entitled to vote at the meeting or any adjournments thereof.
Your attention is directed to the Proxy Statement accompanying this Notice for a more complete statement of the matters to be considered
at the meeting. A copy of the Annual Report on Form 10-K for the year ended December 31, 2018 also accompanies this Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.2in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">By Order of the Board of Directors,</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Brian Sullivan</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Chairman of the Board of Directors and&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Date: April 3, 2019</TD>
    <TD>Chief Executive Officer </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Your vote is important. To vote your
shares, please vote by telephone or Internet, as directed in the Proxy Statement, or, if you received a proxy card or voting instruction
form by mail, please complete, sign, date and mail the proxy card or voting instruction form promptly in the envelope provided.
The prompt return of proxies will save Celcuity the expense of further requests for proxies. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY
OF PROXY MATERIALS FOR THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MAY 16, 2019:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>This Notice, the Proxy Statement, and
the Annual Report on Form&nbsp;10-K are available at http://proxyvote.com and on the Investor Relations section of Celcuity&rsquo;s
website at http://www.celcuity.com/home/investors/.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CELCUITY INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">16305 36<SUP>th</SUP> Avenue North, Suite
100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Minneapolis, MN 55446</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PROXY STATEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2019 ANNUAL MEETING OF STOCKHOLDERS</B><BR>
<B>to be held on May 16, 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Proxy Statement is furnished in connection
with the solicitation of proxies by the Board of Directors (the &ldquo;Board&rdquo;) of Celcuity Inc., a Delaware corporation (&ldquo;Celcuity,&rdquo;
the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; or &ldquo;us&rdquo;), for use at the 2019 Annual Meeting of Stockholders
(the &ldquo;Annual Meeting&rdquo;) to be held at the Celcuity corporate offices, 16305 36th Avenue North, Suite 100, Minneapolis,
MN 55446, at 2:00 p.m. local time on May 16, 2019.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Purposes of the Annual Meeting</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The purposes of the Annual Meeting are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -18.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: left">To elect the five director nominees named in this Proxy
Statement to the Celcuity Board of Directors, to serve until the earlier of the next annual meeting of stockholders, the election
of such director&rsquo;s successor, or such director&rsquo;s death, resignation or removal;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -18.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: left">To ratify the appointment of Boulay PLLP as Celcuity&rsquo;s
independent registered public accounting firm for the year ending December 31, 2019;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -18.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">To approve, on an advisory basis, named executive officer
compensation; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -18.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: left">To transact any other business as may properly come
before the meeting or any adjournments thereof, including matters incident to the conduct of the meeting.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Action may be taken on any one of the foregoing
proposals on the date specified above for the Annual Meeting, or on any date or dates to which the Annual Meeting may be adjourned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Notice and Access Delivery</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with rules and regulations
adopted by the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;), we have elected to provide our beneficial owners
and stockholders of record access to our proxy materials over the Internet. Beneficial owners are stockholders whose shares are
held in the name of a broker, bank or other nominee (i.e., in &ldquo;street name&rdquo;). Accordingly, a Notice of Internet Availability
of Proxy Materials (the &ldquo;Notice&rdquo;) will be mailed on or about&nbsp;April&nbsp;3, 2019&nbsp;to our beneficial owners
and stockholders of record who owned our common stock at the close of business on&nbsp;March 18, 2019. Beneficial owners and stockholders
of record will have the ability to access the proxy materials on a website referred to in the Notice or to request a printed set
of the proxy materials be sent to them by following the instructions in the Notice. Beneficial owners and stockholders of record
who have previously requested to receive paper copies of our proxy materials will receive paper copies of the proxy materials instead
of a Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You can choose to receive our future proxy
materials electronically by visiting http://www.proxyvote.com. Your choice to receive proxy materials electronically will remain
in effect until you instruct us otherwise by following the instructions contained in your Notice and visiting http://www.proxyvote.com,
sending an email to sendmaterial@proxyvote.com, or calling 1-800-579-1639.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Solicitation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This solicitation is made by Celcuity,
and Celcuity will pay the cost of soliciting proxies for the Annual Meeting. In addition to soliciting proxies by mail, we may
solicit proxies personally or by telephone, email, facsimile or other means of communication by our directors, officers and employees.
These persons will not specifically be compensated for these activities, but they may be reimbursed for reasonable out-of-pocket
expenses in connection with this solicitation. We will not specifically engage any employees or paid solicitors for the purpose
of soliciting proxies for the Annual Meeting. We will arrange with brokerage firms and other custodians, nominees and fiduciaries
to forward solicitation materials to the beneficial owners of shares held of record by these persons. We will reimburse these brokerage
firms, custodians, nominees and fiduciaries for reasonable out-of-pocket expenses incurred by them in connection with this solicitation.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Record Date and Shares Outstanding</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Only holders of record of our common stock
at the close of business on March 18, 2019 will be entitled to vote at the Annual Meeting or any adjournments thereof. As of March
18, 2019, there were 10,209,115 shares of our common stock, outstanding and entitled to vote. Each share of common stock entitles
the holder thereof to one vote upon each matter to be presented at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If you are a stockholder of record, you
may vote in person at the Annual Meeting, vote by proxy using the enclosed proxy card (if you received paper copies of the proxy
materials), vote by proxy over the telephone, or vote by proxy over the Internet. Whether or not you plan to attend the Annual
Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the Annual Meeting and vote in person
even if you have already voted by proxy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">To vote in person, come to the Annual Meeting and we will give you
a ballot when you arrive.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">If you received paper copies of the proxy materials, to vote using
the proxy card, simply complete, sign and date the enclosed proxy card and return it promptly in the envelope provided. If you
return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>To vote over the telephone, dial toll-free 1-800-690-6903 using a touch-tone phone and follow the recorded instructions. Please
have available the 16-Digit Control Number from the enclosed proxy card, if you received one, or from your Notice. Your vote must
be received by 11:59 p.m., Eastern Time (10:59 p.m., Central Time) on May 15, 2019, to be counted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>To vote over the Internet, go to http://www.proxyvote.com to complete an electronic proxy card. Please have available the 16-Digit
Control Number from the enclosed proxy card, if you received one, or from your Notice. Your vote must be received by 11:59 p.m.,
Eastern Time (10:59 p.m., Central Time) on May 15, 2019, to be counted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>We are providing Internet proxy voting
to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote
instructions. However, please be aware that you must bear any costs associated with your Internet access, such as usage charges
from Internet access providers and telephone companies.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If you are a beneficial owner of shares
registered in the name of your broker, bank, or other nominee, you may have received a proxy card and voting instructions with
these proxy materials from that organization rather than from us. Simply complete and mail the proxy card to ensure that your vote
is submitted to your broker. Alternatively, you may vote by telephone or over the Internet as instructed by your broker. To vote
in person at the Annual Meeting, you must obtain a valid proxy from your broker. Follow the instructions from your broker included
with these proxy materials, or contact your broker to request a proxy form.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Quorum</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A quorum, consisting of a majority of the
outstanding shares of our common stock entitled to vote at the Annual Meeting, must be present in person or by proxy before any
action can be taken by the stockholders at the Annual Meeting. Abstentions and withheld votes are counted as present and entitled
to vote for purposes of determining a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If you are a beneficial owner of shares
registered in the name of your broker, bank, or other nominee, such shares may be voted by the broker on &ldquo;routine&rdquo;
matters, which includes ratification of the appointment of our independent registered public accounting firm (Proposal 2). All
other proposals in this Proxy Statement are considered &ldquo;non-routine.&rdquo; Your broker will not be able to vote your shares
on non-routine matters being considered at the Annual Meeting unless you have given instructions to your broker prior to the meeting
on how to vote your shares. When the broker does not obtain direction to vote the shares, the broker&rsquo;s abstention is referred
to as a &ldquo;broker non-vote.&rdquo; Broker non-votes will be considered present for quorum purposes at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">So long as a quorum is present at the beginning
of the Annual Meeting, the stockholders present may continue to transact business until adjournment, even if enough stockholders
have left the meeting to leave less than a quorum, and even if any stockholder present in person or by proxy refuses to vote or
participate in the Annual Meeting. If the Annual Meeting is adjourned for any reason, the approval of the proposals may be considered
and voted upon by stockholders at the subsequent reconvened meeting. All proxies will be voted in the same manner as they would
have been voted at the original Annual Meeting except for any proxies that have been properly withdrawn or revoked.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board Recommendation and Voting of Proxies</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board recommends a vote:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>FOR</B> the election of each of the director nominees (Proposal 1).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>FOR</B> the ratification of the appointment of Boulay PLLP as our independent registered public accounting firm for the
year ending December 31, 2019 (Proposal 2).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>FOR </B>the approval, on an advisory basis, of named executive officer compensation (Proposal 3).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If you complete and submit your proxy before
the Annual Meeting, the persons named as proxy agents will vote the shares represented by your proxy in accordance with your instructions.
If you submit a proxy without giving voting instructions, your shares will be voted in the manner recommended by the Board on all
matters presented in this Proxy Statement. If any other matters are properly presented for consideration at the Annual Meeting,
including, among other things, consideration of a motion to adjourn the Annual Meeting to another time or place (including, without
limitation, for the purpose of soliciting additional proxies), the persons named as proxy agents will have discretion to vote on
those matters in accordance with their best judgment. We do not currently anticipate that any other matters will be raised at the
Annual Meeting.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Vote Required</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the election of directors, you have
the option to vote &ldquo;For&rdquo; or &ldquo;Withhold&rdquo; authority to vote for any of the director nominees. Assuming a quorum
is present, a plurality of the votes cast is required for the election of directors. This means that the five director nominees
with the most votes will be elected. If you &ldquo;Withhold&rdquo; authority to vote on any or all nominees, your vote will have
no effect on the outcome of the election. If you hold your shares in &ldquo;street name&rdquo; and do not provide instructions
to your broker, your broker will not have discretionary authority with respect to the proposal to elect directors and will therefore
provide a &ldquo;broker non-vote.&rdquo; Since broker non-votes are not deemed votes cast, they will have no effect on the outcome
of the election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the ratification of the appointment
of Boulay PLLP as our independent registered public accounting firm, you have the option to vote &ldquo;For,&rdquo; &ldquo;Against&rdquo;
or &ldquo;Abstain&rdquo; from voting. Assuming a quorum is present, the affirmative vote of a majority of the shares of common
stock of Celcuity represented at the Annual Meeting, either in person or by proxy, and entitled to vote is required to ratify the
appointment of Boulay PLLP as our independent registered public accounting firm. If you &ldquo;Abstain&rdquo; from voting with
respect to this proposal, your shares will be counted as present and entitled to vote and your vote will have the same effect as
a vote against the proposal. If you hold your shares in &ldquo;street name&rdquo; and do not provide instructions to your broker,
your broker will have discretionary authority to vote your shares with respect to this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the approval, on an advisory basis,
of the compensation of our named executive officers, you have the option to vote &ldquo;For,&rdquo; &ldquo;Against&rdquo; or &ldquo;Abstain&rdquo;
from voting. Assuming a quorum is present, the affirmative vote of a majority of the shares of common stock of Celcuity represented
at the Annual Meeting, either in person or by proxy, and entitled to vote is required to approve the compensation of our named
executive officers. If you mark &ldquo;Abstain&rdquo; from voting with respect to this proposal, your shares will be counted as
present and entitled to vote and your vote will have the same effect as a vote against the proposal. If you hold your shares in
&ldquo;street name&rdquo; and do not provide instructions to your broker, your broker will not have discretionary authority to
vote your shares with respect to this proposal and will therefore provide a &ldquo;broker non-vote.&rdquo; Since broker non-votes
are not deemed entitled to vote, they will have no effect on the outcome of the proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The vote on approval of the compensation
of our named executive officers is an advisory vote, which means that the result of the vote is not binding on the Company, our
Board or the Compensation Committee. To the extent there is any significant vote against our named executive officer compensation
as disclosed in this Proxy Statement, the Board and the Compensation Committee will evaluate whether any actions are necessary
to address the concerns of stockholders.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revocability of Proxies</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any person giving a proxy for the Annual
Meeting has the power to revoke it at any time before it is voted. If you are a record holder of your shares, you may revoke your
proxy in any one of the following ways: (1) sending a written notice of revocation dated after the date of the proxy to our Corporate
Secretary, Celcuity Inc., 16305 36<SUP>th</SUP> Avenue North, Suite 100, Minneapolis, MN 55446; (2) submitting a properly signed
proxy with a later date; (3) submitting a new vote by telephone or Internet; or (4) attending the Annual Meeting and voting in
person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35pt">If you are a beneficial owner of shares registered
in the name of your broker, bank, or other nominee, you must contact them in order to find out how to revoke your proxy. Attendance
at the Annual Meeting will not, in and of itself, constitute a revocation of a proxy if you hold your shares in &ldquo;street name.&rdquo;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other Business</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Although the notice of Annual Meeting provides
for the transaction of such other business as may properly come before the Annual Meeting, our Board currently has no knowledge
of any matters to be presented at the Annual Meeting other than those referred to in this Proxy Statement. The solicited proxies
give discretionary authority to the proxy agents named therein to vote in accordance with the recommendation of the Board if any
other matters are presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FINANCIAL INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our 2018 Annual Report on Form 10-K filed
with the SEC, including, but not limited to, the balance sheets and the related statements of operations, changes in stockholders&rsquo;
equity and cash flows for Celcuity as of and for the years ended December 31, 2018 and 2017 accompanies these materials. A copy
of the 2018 Annual Report on Form 10-K may be obtained without charge upon request to our Chief Financial Officer, Celcuity Inc.,
16305 36th Avenue North, Suite 100, Minneapolis, MN 55446. Our 2018 Annual Report on Form 10-K is also available on our website
at http://www.celcuity.com/home/investors/sec-filings/.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PROPOSAL NO. 1<BR>
ELECTION OF DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Celcuity&rsquo;s business and affairs are
managed under the direction of the Board. All of our directors are elected at each annual meeting to serve until their successors
are duly elected or until their earlier death, resignation or removal. If any of the nominees for director at the Annual Meeting
becomes unavailable for election for any reason (none being presently known), the proxy agents will have discretionary authority
to vote, pursuant to the proxies, for a suitable substitute or substitutes selected in accordance with the best judgment of the
proxy agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Nominees for Election</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board, upon the recommendation of the
Nominating and Corporate Governance Committee, has nominated the five persons named in the table below for election as directors
at the Annual Meeting. Each nominee listed below currently serves as a director of Celcuity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; width: 18%; border-bottom: Black 1pt solid"><B>Name of Nominee</B></TD>
    <TD STYLE="vertical-align: top; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 5%; border-bottom: Black 1pt solid; text-align: center"><B>Age</B></TD>
    <TD STYLE="vertical-align: top; width: 1%; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 60%; border-bottom: Black 1pt solid; text-align: center"><B>Position Held with Celcuity Inc.</B></TD>
    <TD STYLE="vertical-align: top; width: 1%; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 14%; border-bottom: Black 1pt solid; text-align: center"><B>Director Since</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Maureen Cronin</TD>
    <TD>&nbsp;</TD>
    <TD>66</TD>
    <TD>&nbsp;</TD>
    <TD>Director</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">2017</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>David F. Dalvey</TD>
    <TD>&nbsp;</TD>
    <TD>60</TD>
    <TD>&nbsp;</TD>
    <TD>Director</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">2014</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Lance G. Laing</TD>
    <TD>&nbsp;</TD>
    <TD>57</TD>
    <TD>&nbsp;</TD>
    <TD>Director, Chief Science Officer, Vice President, and Secretary</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">2012</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Richard J. Nigon</TD>
    <TD>&nbsp;</TD>
    <TD>71</TD>
    <TD>&nbsp;</TD>
    <TD>Director</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">2017</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Brian F. Sullivan</TD>
    <TD>&nbsp;</TD>
    <TD>57</TD>
    <TD>&nbsp;</TD>
    <TD>Chairman of the Board and Chief Executive Officer</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">2012</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board has determined that each of Maureen
Cronin, David F. Dalvey, and Richard J. Nigon qualifies as an independent director under the rules of the Nasdaq Stock Market (the
&ldquo;Nasdaq Listing Rules&rdquo;). Accordingly, the Board is and will be composed of a majority of independent directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Set forth below with respect to each director
nominee standing for election at the 2019 Annual Meeting are such nominee&rsquo;s principal occupation and business experience
during at least the past five years, the names of other publicly-held companies for which such nominee serves or has served as
a director during such period, and the experience, qualifications, attributes or skills that has led the Board to conclude that
each nominee should serve as a director of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Maureen Cronin, Ph.D</I>. is currently
the Chief Science Officer and Senior Vice President of Research and Development at HTG Molecular Diagnostics, Inc. Prior to this
role, she served as Executive Director of Research Informatics at Celgene Corporation from 2012 through 2017. Dr. Cronin&rsquo;s
career spans more than 25 years in biotechnology research and development and drug discovery research. She has served at seven
biotechnology or molecular diagnostics startups, including service as a senior research executive at two leading oncology precision
medicine diagnostics companies. From 2001 to 2010, she was Vice President of Research at Genomic Health, Inc. and from 2010 to
2012, she was Vice President of Research and Development at Foundation Medicine, Inc. Her technology research and development career
began at Affymetrix (purchased by Thermo Fisher). She currently serves as a director of a privately-held company. She received
her doctorate in physiology and pharmacology from University of California, San Diego as a Regents&rsquo; Fellow and completed
a UCSD post-doctoral fellowship at the San Diego VA Hospital. She has been named an inventor on 17 U.S. and 11 European patents
and has authored or coauthored more than 40 peer reviewed publications. Her work at diagnostics and drug development companies
gives her unique expertise and experience in developing and delivering precision medicine tests. Among other attributes, skills,
and qualifications, the Board believes Dr. Cronin is uniquely qualified to serve as a director based on her significant diagnostics
research and applied scientific expertise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>David F. Dalvey</I> has served as a
member of Celcuity&rsquo;s Board since February&nbsp;2014. Mr.&nbsp;Dalvey has more than 30 years of experience in the fields of
corporate finance and venture capital, working primarily with growth-oriented technology and life-science businesses. He has over
10 years of corporate finance advisory experience with two national investment banks, completing over 150 individual transactions.
He has been the General Partner of Brightstone Venture Capital, a venture capital management company, since September&nbsp;2000.
Brightstone is a 25-year old venture capital management company that has raised and managed ten venture partnerships. Previously,
he held management positions with R.J. Steichen and Company, an investment bank, from 1995 to 2000, The Food Fund LP, a venture
capital firm, from 1992 to 1995 and Wessels, Arnold &amp; Henderson, an investment bank, from 1987 to 1992. Mr. Dalvey served on
the board of directors for Navarre Corporation (now Speed Commerce, Inc.) from 2009 until November&nbsp;2012, on the board of managers
for Blue Rock Market Neutral Fund, a mutual fund registered under the Investment Company Act of 1940, from 2000 to 2014 and on
the board of directors for Digitiliti, Inc. from July&nbsp;2011 until October&nbsp;2012. Mr. Dalvey has significant operational
exposure as a board director or advisor to many other public and privately held growth businesses and has served on these companies&rsquo;
audit, strategic or governance committees, including companies such as HomeSpotter, Definity Health, AppTec Laboratories, CHF Solutions,
BiteSquad, Agiliti, and Nature Vision. Mr. Dalvey received a B.S. in Business/Management Economics from University of Minnesota.
Among other attributes, skills, and qualifications, the Board believes Mr. Dalvey is uniquely qualified to serve as a director
based on his leadership experience in operating both public and private companies and his experience working in the investment
community and with investment firms, which enable him to bring valuable insight and knowledge to our Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Lance G. Laing, Ph.D.</I> is our co-founder
and has served as Chief Science Officer, Vice President, Secretary and Director since we commenced operations in 2012. Dr. Laing&rsquo;s
career spans more than 15 years in drug discovery research and technology development. He received his doctorate in biophysics
and biochemistry from The Johns Hopkins University and completed a National Institutes of Health post-doctoral fellowship at Washington
University Medical School. He has received 19 U.S. patents and has an additional 24 U.S. patents pending. His drug discovery research
career began at Scriptgen/Anadys Pharmaceuticals (purchased by Novartis), where he worked under Professor Peter Kim, who became
President of Merck Research. He also was Director of Chemistry and Bioapplications and Director of Detection Product Development
for two companies that each developed instruments similar to those Celcuity uses to perform the CELx tests. His work at these two
instrument companies gave him unique expertise and experience in developing a variety of patented applications for these instruments.
Most recently, he served as an executive director for an international drug discovery and development company. Among other attributes,
skills, and qualifications, the Board believes Dr. Laing is uniquely qualified to serve as a director based on his significant
research, medical and scientific expertise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Richard J. Nigon</I> is currently Senior
Vice President of Cedar Point Capital, LLC, a private company that raises capital for early stage companies, where he has served
since 2007. Mr. Nigon has also been a board member for Tactile Systems Technology since September&nbsp;2012 and Northern Technologies
International Corp. since February&nbsp;2010, including as its non-executive Chairman of the board of directors since November&nbsp;2012.
Mr. Nigon also serves as a director of several private companies. Mr. Nigon previously served as a board member for Vascular Solutions,
Inc. from November&nbsp;2000 to February&nbsp;2017, when it was acquired by Teleflex, Incorporated, and as a board member for Virtual
Radiologic Corporation from May&nbsp;2007 until it was acquired in July&nbsp;2010. From February&nbsp;2001 until December&nbsp;2006,
Mr. Nigon was a Director of Equity Corporate Finance for Miller Johnson Steichen Kinnard, a privately held investment firm, which
was acquired in December&nbsp;2006 by Stifel Nicolaus, a brokerage and investment banking firm. After that acquisition, Mr. Nigon
was a Managing Director of Private Placements of Stifel Nicolaus until May&nbsp;2007. From February&nbsp;2000 to February&nbsp;2001,
Mr. Nigon served as the Chief Financial Officer of Dantis, Inc., a web hosting company. Prior to joining Dantis, Mr. Nigon was
employed by Ernst &amp; Young LLP from 1970 to 2000, where he served as a partner from 1981 to 2000. While at Ernst &amp; Young,
Mr. Nigon served as the Director of Ernst &amp; Young&rsquo;s Twin Cities Entrepreneurial Services Group and was the coordinating
partner on several publicly-traded companies in the consumer retailing and manufacturing sectors. We believe Mr. Nigon is qualified
to serve on our Board because of his extensive public accounting and auditing experience, including particular experience with
emerging growth companies. We also believe that he brings to the Board a strong background in financial controls and reporting,
financial management, financial analysis, SEC reporting requirements and mergers and acquisitions. His strategic planning expertise
gained through his management and leadership roles at private investment firms also makes him well-suited to serve as a member
of our Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Brian F. Sullivan</I> is our
co-founder and has served as Chairman of the Board and Chief Executive Officer since we commenced operations in 2012. Mr.
Sullivan has over 25 years of experience founding and building successful, high growth technology companies. He was Chairman
and CEO of SterilMed, a medical device reprocessing company, from 2003, when he led an investment group to acquire a majority
interest, until its sale to Ethicon Endo-Surgery Inc., a Johnson &amp; Johnson company, for $330 million in 2011. Previously,
he was co-founder and Chief Executive Officer of Recovery Engineering, a filtration company, which he took public and
subsequently sold to Procter &amp; Gamble for $265 million in 1999. Since 2003, Mr. Sullivan has served on the board of
directors of Entegris, Inc., a publicly-held company. Mr.&nbsp;Sullivan has received  six U.S. patents and has several
patents pending. He graduated <I>magna cum laude</I> with distinction from Harvard College with an A.B. in economics. Among
other attributes, skills, and qualifications, the Board believes Mr.&nbsp;Sullivan is uniquely qualified to serve as a
director based on his extensive operational and business development experience, and his knowledge in building stockholder
value, growing a company from inception and navigating significant corporate transactions and the public company process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Assuming a quorum is present, the affirmative
vote of a plurality of the votes cast at the Annual Meeting is required for the election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE BOARD OF DIRECTORS RECOMMENDS THAT
THE</B><BR>
<B>STOCKHOLDERS VOTE <I><U>FOR</U></I> THE SLATE OF NOMINEES NAMED ABOVE.</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PROPOSAL NO. 2<BR>
RATIFICATION OF APPOINTMENT OF<BR>
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Boulay LLP (&ldquo;Boulay&rdquo;), an independent
registered public accounting firm, has audited the Company&rsquo;s financial statements for the years ended December 31, 2018,
and 2017. The Audit Committee appointed Boulay as the Company&rsquo;s independent registered public accounting firm for the year
ending December 31, 2019 and has also reviewed and approved the scope and nature of the services to be performed for Celcuity by
Boulay. Representatives of Boulay are expected to be present at the Annual Meeting to make a statement if they wish to do so, and
to respond to appropriate stockholder questions. The engagement agreement entered into with Boulay for 2019 is subject to mediation
and arbitration procedures as the sole method for resolving disputes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Ratification of the appointment of Boulay
as the Company&rsquo;s independent registered public accounting firm is not required to be submitted to our stockholders for a
vote. The Sarbanes-Oxley Act of 2002 requires the Audit Committee to be directly responsible for the appointment, compensation
and oversight of the audit work of the independent registered public accounting firm. However, the Board is submitting this matter
to the stockholders for ratification as a matter of good corporate governance. If the appointment of Boulay is not ratified by
the stockholders at the Annual Meeting, the Audit Committee may reconsider whether to retain Boulay, and may retain Boulay or another
firm without resubmitting the matter to the Company&rsquo;s stockholders. Even if the stockholders vote in favor of ratification
of the appointment, the Audit Committee may, in its discretion, direct the appointment of a different independent registered public
accounting firm at any time during the year if it determines that such a change would be in the best interests of the Company and
the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Representatives of Boulay regularly attend
meetings of the Audit Committee. The Audit Committee preapproves, and reviews audit and non-audit services performed by Boulay,
as well as the fees charged by Boulay for such services. In its pre-approval and review of non-audit service fees, the Audit Committee
considers, among other factors, the possible effect of the performance of such services on Boulay&rsquo;s independence. To avoid
potential conflicts of interest, publicly traded companies are prohibited from obtaining certain non-audit services, such as bookkeeping
or actuarial services, from its independent registered public accounting firm. In 2018 and 2017, we did not obtain any of these
prohibited services from Boulay. For additional information concerning the Audit Committee and its relationship with Boulay, see
&ldquo;Corporate Governance&rdquo; and &ldquo;Report of the Audit Committee&rdquo; below.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Audit and Non-Audit Fees Billed to the Company by Independent
Registered Public Accounting Firm</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table summarizes the fees
we were billed for audit and non-audit services rendered by Boulay for 2018 and 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Audit Fees</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">55,728</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">56,339</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Audit-Related Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Tax Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,900</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">All Other Fees</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,395</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">55,825</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">61,123</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">115,064</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Audit Fees</I>.&nbsp;&nbsp;These fees
were for professional services rendered for 2018 and 2017 in connection with the audit of our annual financial statements and review
of the financial statements included in our Quarterly Reports on Form 10-Q.&nbsp;&nbsp;The amounts also include fees for services
that are normally provided by Boulay in connection with statutory and regulatory filings and engagements for the years identified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Audit-Related Fees</I>.&nbsp;&nbsp;These
fees were for assurance and related services that were related to the performance of the audit or review of our financial statements
and were not reported under the caption &ldquo;Audit Fees.&rdquo;&nbsp;This category may include fees related to the performance
of audits and attestation services not required by statute or regulations, or accounting consultations about the application of
generally accepted accounting principles to proposed transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Tax Fees</I>.&nbsp;These fees were for
tax compliance, tax planning, tax advice and corporate tax services. Corporate tax services encompass a variety of permissible
services, including technical tax advice related to tax matters; assistance with withholding-tax matters; assistance with state
and local taxes; preparation of reports to comply with local tax authority transfer pricing documentation requirements; and assistance
with tax audits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>All Other Fees.</I>&nbsp;These fees were
primarily for services related to our Registration Statement on Form S-3 in 2018 and our Registration Statement on Form S-1 in
2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Pre-Approval Policy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The charter of the Audit Committee requires
the pre-approval of all non-audit services before any such non-audit services are performed for the Company. The charter of the
Audit Committee is posted on the Company&rsquo;s website at http:// http://www.celcuity.com/home/investors/corporate-governance/.
We formed our Audit Committee in connection with our initial public offering in 2017. All fees listed for 2018 or for 2017 that
were incurred after formation of our Audit Committee received pre-approval by the Audit Committee. In addition, the Audit Committee
has reviewed all other fees listed as paid in 2017 and concluded that such fees were in accordance with the Audit Committee&rsquo;s
policies and procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Assuming a quorum is present, the affirmative
vote of a majority of the shares of common stock of Celcuity represented at the Annual Meeting, either in person or by proxy, and
entitled to vote is required to ratify the appointment of Boulay as our independent registered public accounting firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE BOARD OF DIRECTORS RECOMMENDS THAT
THE STOCKHOLDERS VOTE <I><U>FOR</U></I> RATIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE APPOINTMENT OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PROPOSAL NO. 3<BR>
ADVISORY VOTE ON NAMED EXECUTIVE OFFICER COMPENSATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Dodd-Frank Wall Street Reform and Consumer
Protection Act and Section 14A of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), requires companies
to provide their stockholders with the opportunity to vote to approve, on a non-binding, advisory basis, the compensation of their
named executive officers. We are an &ldquo;emerging growth company&rdquo; as defined under the Jumpstart Our Business Startups
Act (the &ldquo;JOBS Act&rdquo;), and are therefore not required to provide our stockholders with this opportunity. However, because
we seek to closely align the interests of our named executive officers with the interests of our stockholders, our Board is nonetheless
requesting our stockholders approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed
in this Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We designed our compensation program to
reward our named executive officers for their individual performance and contributions to our overall business objectives, and
for achieving and surpassing the financial goals set by our Compensation Committee and our Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The vote on this resolution is not intended
to address any specific element of compensation. Instead, the vote relates to the overall compensation of our named executive officers,
as described in this Proxy Statement in accordance with the compensation disclosure rules of the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Accordingly, we ask our stockholders to
vote on the following resolution at the Annual Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;RESOLVED, that the Company&rsquo;s
stockholders approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Company&rsquo;s
Proxy Statement for the 2019 Annual Meeting of Stockholders pursuant to the compensation disclosure rules of the SEC, including
the summary compensation table and the other related tables and disclosure.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">While the Board and especially the Compensation
Committee intend to carefully consider the results of the voting on this proposal when making future decisions regarding executive
compensation, the vote is not binding on the Company or the Board and is advisory in nature. To the extent there is any significant
vote against the compensation of our named executive officers, the Board and the Compensation Committee will evaluate what actions
may be necessary to address our stockholders&rsquo; concerns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Assuming a quorum is present, the affirmative
vote of a majority of the shares of common stock of Celcuity represented at the Annual Meeting, either in person or by proxy, and
entitled to vote is required to approve the compensation of our named executive officers. This vote is advisory and is not binding
on the Company, the Board or the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE BOARD OF DIRECTORS RECOMMENDS THAT
THE STOCKHOLDERS VOTE <I><U>FOR</U></I> THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPROVAL OF THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CORPORATE GOVERNANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board believes that adherence to good corporate governance principles is essential to running our business efficiently, to maintaining
our integrity in the marketplace, and to ensuring that the Company is managed for the long-term benefit of our stockholders. The
Board recognizes that maintaining and ensuring good corporate governance is a continuous process. Our Board has adopted the Celcuity
Inc. Code of Ethical Business Conduct for Senior Financial Officers (the &ldquo;Code of Ethics&rdquo;) and a charter for each committee
of the Board. The Code of Ethics and the Charters of the Audit Committee, the Compensation Committee and the Nominating and Governance
Committee, as amended from time to time, are available on the Company&rsquo;s website at http://www.celcuity.com/home/investors/corporate-governance/
and will be provided in printed form to any stockholder who requests them from us. Requests should be </FONT>directed to Investor
Relations, Celcuity Inc., 16305 36<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT> Avenue North, Suite 100, Minneapolis, Minnesota
55446.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our bylaws provide that the size of our
Board will be determined from time to time by resolution of our Board. The Board has determined that Maureen Cronin, David G. Dalvey,
and Richard J. Nigon are independent directors under the Nasdaq Listing Rules. Under our bylaws, a director elected for an indefinite
term serves until the next regular meeting of the stockholders and until the director&rsquo;s successor is elected, or until the
earlier death, resignation or removal of the director. Our bylaws provide that members of our Board will be elected by a plurality
vote of our stockholders.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board Leadership Structure</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our bylaws provide our Board with flexibility
to combine or separate the positions of Chairman of our Board and Chief Executive Officer and/or to implement a presiding or lead
director in accordance with its determination that utilizing one or the other structure would be in the best interests of the Company.
Brian F. Sullivan, our Chief Executive Officer, is the Chairman of our Board. We believe that this leadership structure is appropriate
at this time because:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">it promotes unified leadership and direction for the
Company;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">it allows for a single, clear focus for management
to execute the Company&rsquo;s strategic initiatives and business plans;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">our Chief Executive Officer is in the best position
to chair board meetings and to ensure that the key business issues and risks facing the Company are brought to the Board&rsquo;s
attention; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">we can more effectively execute our strategy and business
plans to maximize stockholder value if the Chairman of the Board is also a member of the management team.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34.5pt">Our Board will periodically review our
leadership structure and may make such changes in the future as it deems appropriate.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Family Relationships</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Dr. Laing, our Chief Science Officer and
a director, is a brother-in-law of Mr. Sullivan, our Chairman and Chief Executive Officer.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Involvement in Certain Legal Proceedings</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To the best of our knowledge, none of our
directors or executive officers have, during the past ten years, been involved in any legal proceedings described in subparagraph
(f) of Item 401 of Regulation S-K.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Risk Oversight</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Board has oversight responsibility for
the Company&rsquo;s risk management process. The Board administers its oversight function through its committees, but retains responsibility
for general oversight of risks. The committee chairs are responsible for reporting findings regarding material risk exposure to
the Board as quickly as possible. The Board delegates to the Audit Committee oversight responsibility to review our Code of Ethics,
including whether the Code of Ethics is successful in preventing illegal or improper conduct, and our management&rsquo;s risk assessments
and management&rsquo;s financial risk management policies, including the policies and guidelines used by management to identify,
assess and manage our exposure to financial risk. Our Compensation Committee assesses and monitors any major compensation-related
risk exposures and the steps management should take to monitor or mitigate such exposures.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Code of Ethics</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have adopted a Code of Ethics applicable
to our principal executive officer and principal financial and accounting officer, in accordance with Section 406 of the Sarbanes-Oxley
Act, the rules of the SEC promulgated thereunder, and the Nasdaq Listing Rules. In the event that any changes are made to, or any
waivers given from, the Code of Ethics, these events would be disclosed on our website or in a Current Report on Form 8-K filed
with the SEC within four business days of such event. The Code of Ethics is posted on our website at http://www.celcuity.com/home/investors/corporate-governance/.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16.5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MEETINGS AND COMMITTEES OF THE BOARD
OF DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During 2018, our Board met four times. During
2018, all directors attended in person or via teleconference 100% of the meetings that occurred during each director&rsquo;s service
on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The standing committees of our Board are
the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee. During 2018, the Audit Committee
met five times, the Compensation Committee met twice, and the Nominating and Corporate Governance Committee met once. All directors
attended at least 75% of the meetings of each committee on which they served.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Executive Sessions; Attendance at Annual Meeting of Stockholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The independent members of the Board periodically
meet outside the presence of management. The Audit Committee has adopted a policy of meeting in executive session, without management
being present, on a regular basis. During 2018, the members of the Audit Committee met in executive session once.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">It is the policy of the Board that each
member of the Board should attend our annual meetings of stockholders whenever practical and that at least one member of the Board
must attend each annual meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Audit Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have established an Audit Committee in
accordance with Section 3(a)(58)(A) of the Exchange Act. The primary duties and responsibilities of our Audit Committee are to
oversee (1) the integrity of our accounting and financial reporting processes and the audits of our financial statements; (2) our
systems of internal controls; (3) our Code of Ethics; and (4) our compliance with legal and regulatory requirements. In addition,
our Audit Committee appoints and monitors the independence, qualifications and performance of our independent auditors, provides
an avenue of communication between our independent auditors, management and the Board; and reviews and approves related party transactions
as required by the Nasdaq Listing Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Dr. Cronin, Mr. Dalvey and Mr. Nigon are
the members of our Audit Committee. The members of the Audit Committee are &ldquo;independent directors&rdquo; as that term is
defined in Rules 5605(a)(2) and 5605(c)(2)(A) of the Nasdaq Listing Rules and Rule 10A-3 of the Exchange Act. The Board has determined
that Mr. Nigon and Mr. Dalvey are each an &ldquo;audit committee financial expert&rdquo; as defined by Item 407(d)(5)(ii) of Regulation
S-K. The Audit Committee operates under a written charter that satisfies the applicable standards of the SEC and the Nasdaq Listing
Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Compensation Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have established a Compensation Committee.
Our Compensation Committee reviews and approves corporate goals and objectives relevant to compensation of our chief executive
officer and other executive officers, evaluates the performance of these officers in light of those goals and objectives, and sets
the compensation of these officers based on such evaluations. The Compensation Committee also reviews and makes recommendations
to the Board with respect to director compensation and the issuance of stock options, restricted stock and other awards under our
equity compensation plans. The Compensation Committee reviews and prepares the necessary compensation disclosures required by the
SEC. Additionally, the Compensation Committee reviews and evaluates, on an annual basis, the Compensation Committee charter and
performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Compensation Committee has approved
the compensation arrangements currently in place for our named executive officers. The Compensation Committee evaluates the performance
of our Chairman and Chief Executive Officer and determines his compensation based on this evaluation without our Chairman and Chief
Executive Officer present during voting or deliberations on his compensation. With respect to the other named executive officers,
the Compensation Committee considers the recommendations of our Chairman and Chief Executive Officer as to performance evaluations
and recommended compensation arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Compensation Committee may approve executive
compensation arrangements or, in its discretion, may recommend such matters to the full Board for approval. All executive compensation
is based on assessments of executive performance, which are prepared by the Compensation Committee and submitted to the full Board
for review and discussion. All Compensation Committee recommendations regarding director compensation are subject to approval by
the full Board. Pursuant to its charter, the Compensation Committee may delegate any of its responsibilities to a subcommittee
comprised of one or more members of the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Dr. Cronin, Mr. Dalvey and Mr. Nigon are
the members of our Compensation Committee. The members of the Compensation Committee are &ldquo;independent directors&rdquo; as
that term is defined in Rule 5605(a)(2) of the Nasdaq Listing Rules and qualify as &ldquo;non-employee directors&rdquo; under Rule
16b-3 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Nominating and Corporate Governance Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34.5pt">We have established a Nominating and Corporate
Governance Committee. Dr. Cronin, Mr. Dalvey and Mr. Nigon are the members of our Nominating and Corporate Governance Committee.
The members of the Nominating and Corporate Governance Committee are &ldquo;independent directors&rdquo; as that term is defined
in Rule 5605(a)(2) of the Nasdaq Listing Rules. The principal functions of the Nominating and Corporate Governance Committee are
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">develop and recommend to the Board minimum qualifications
for director nominees;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">identify and evaluate potential candidates for the
Board and committee positions;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">recommend to the Board a slate of nominees for election
as directors at our annual meetings of stockholders;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">recommend to the Board individuals to be appointed
to the Board in connection with vacancies or newly created director positions and the termination of directors for cause or other
appropriate reasons;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">review the size and composition of the Board and its
committees;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">oversee our corporate governance practices;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">evaluate and make recommendations regarding stockholder
proposals submitted to the Board for inclusion in the company&rsquo;s proxy statement; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">develop, recommend and oversee an annual self-evaluation
process for the Board and its committees.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.5pt; text-indent: -0.25in; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">QUALIFICATIONS OF CANDIDATES FOR ELECTION
TO THE BOARD</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and
Corporate Governance Committee identifies and recommends candidates it believes are qualified to stand for election as directors
of Celcuity or to fill any vacancies on the Board. In identifying director candidates, the Nominating and Corporate Governance
Committee may retain third party search firms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In order to evaluate and identify director
candidates, the Nominating and Corporate Governance Committee considers the suitability of each director candidate, including the
current members of the Board, in light of the current size, composition and current perceived needs of the Board. The Nominating
and Corporate Governance Committee seeks highly qualified and experienced director candidates and considers many factors in evaluating
such candidates, including issues of character, judgment, independence, background, age, expertise, diversity of experience, length
of service and other commitments. Additionally, while the Nominating and Corporate Governance Committee does not have a formal
policy with respect to diversity, it seeks to have a Board that is diverse in these factors and gives due consideration to contributions
to diversity on the Board when evaluating the qualifications of any potential director candidate. The Nominating and Corporate
Governance Committee does not assign any particular weight or priority to any of these factors. The Nominating and Corporate Governance
Committee has established the following minimum requirements for director candidates: being able to read and understand fundamental
financial statements; having at least 10 years of relevant business experience; having no identified conflicts of interest as a
director of Celcuity; having not been convicted in a criminal proceeding other than traffic violations during the ten years before
the date of selection; and being willing to comply with any code of ethics of the Company. The Nominating and Corporate Governance
Committee retains the right to modify these minimum qualifications from time to time. Exceptional candidates who do not meet all
of these criteria may still be considered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">The Nominating and Corporate Governance
Committee may review director candidates by reviewing information provided to it, through discussions with persons familiar with
the candidate, or other actions that the Nominating and Corporate Governance Committee deems proper. After such review and consideration,
the Nominating and Corporate Governance Committee designates any candidates who are to be interviewed and by whom they are to be
interviewed. After interviews, the Nominating and Corporate Governance Committee recommends for Board approval any new directors
to be nominated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">The Nominating and Corporate Governance
Committee will consider director candidates recommended by stockholders in the same manner that it considers all director candidates.
Stockholders who wish to nominate a qualified candidate for the 2020 annual meeting must submit such nomination in writing to our
Corporate Secretary, Celcuity Inc., 16305 36<SUP>th</SUP> Avenue North, Suite 100, Minneapolis, MN 55446, in accordance with the
stockholder proposal requirements summarized under &ldquo;Stockholder Proposals&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">BOARD OF DIRECTORS VACANCIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our bylaws authorize only our Board to fill
vacant directorships, including newly created seats. In addition, the number of directors constituting our Board is permitted to
be set only by a resolution adopted by our Board. These provisions prevent a stockholder from increasing the size of our Board
and then gaining control of our Board by filling the resulting vacancies with its own nominees. This makes it more difficult to
change the composition of our Board but promotes continuity of management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">STOCKHOLDER COMMUNICATIONS WITH THE
BOARD OF DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our stockholders may contact our Board,
or any committee of our Board, by regular mail at Chief Executive Officer, Celcuity Inc., 16305 36<SUP>th</SUP> Avenue North, Suite
100, Minneapolis, MN 55446. All communications will be reviewed by management and then forwarded to the appropriate director or
directors or to the full Board, as appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">DIRECTOR COMPENSATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During 2018, Celcuity&rsquo;s non-employee
directors received compensation in the form of an equity award with a fair market value of $50,000 as of May 14, 2018, the date
of grant. Each director could elect to receive the equity award in the form of restricted stock or stock options. Dr. Cronin received
the equity award in the form of restricted stock and Mr. Dalvey and Mr. Nigon received the equity award in the form of a stock
option. Dr. Cronin received 2,571 shares of restricted stock, which was determined by dividing $50,000 by the closing price of
a share of the Company&rsquo;s common stock on the date of grant (rounded up to the next whole share). The restricted stock will
vest with respect to 100% of the shares on April 30, 2019. For the stock options, each option is for the purchase of 3,201 shares,
the number of shares that results in the option having a Black Scholes value of $50,000 as of the date of grant. The stock options
have an exercise price of $19.45 per share, which is equal to the closing price of a share of the Company&rsquo;s common stock
on the date of grant. The stock options will vest and become exercisable with respect to 100% of the shares on April 30, 2019 and
will remain exercisable for the remainder of the 10-year term. The Compensation Committee has not yet determined compensation for
the non-employee directors for 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, non-employee directors are
reimbursed for their out-of-pocket expenses incurred in connection with services as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Fiscal Year 2018 Director Compensation </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The table below summarizes the compensation
paid by the Company to its non-employee directors for the fiscal year ended December 31, 2018. Mr. Sullivan and Dr. Laing are not
included in this table since they are each an employee of the Company and receive no compensation for their services as a director.
Each of Mr. Sullivan and Dr. Laing are included in the Summary Compensation Table under &ldquo;Executive Compensation&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: 1in">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid; text-align: left">Name</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Stock </B><BR> <B>Awards<SUP>(1)(2)</SUP></B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Option </B><BR> <B>Awards<SUP>(1)(3)</SUP></B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; text-align: left">Maureen Cronin</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">50,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">50,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">David F. Dalvey</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Richard J. Nigon</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Reflects the aggregate grant date fair value of equity awards to each director during 2018, calculated in accordance with FASB
ASC Topic 718. Dr. Cronin received 2,571 shares of restricted stock, and Mr. Dalvey and Mr. Nigon each received an option to purchase
3,201 shares of common stock at an exercise price of $19.45. Refer to &ldquo;Note 10 &ndash; Stock-Based Compensation&rdquo; in
the audited financial statements included in Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2018 for
a discussion of the assumptions used in calculating the award amount.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>The aggregate number of shares of restricted stock held by each of the directors listed in the table above as of December 31,
2018 was as follows: Dr. Cronin, 2,571 shares of restricted stock. Neither Mr. Dalvey nor Mr. Nigon hold any shares of restricted
stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>The aggregate number of stock options held by each of the directors listed in the table above as of December 31, 2018 was as
follows: Mr. Dalvey, options to purchase 11,401 shares; and Mr. Nigon, options to purchase 11,401 shares. Dr. Cronin does not hold
any options.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">BENEFICIAL OWNERSHIP OF COMMON STOCK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table contains information
regarding the beneficial ownership of Celcuity&rsquo;s common stock as of March 18, 2019 (except as otherwise indicated) by (i)
each person who is known by Celcuity to beneficially own more than 5% of the outstanding shares of our common stock; (ii) each
director of Celcuity; (iii) each director nominee; (iv) each named executive officer of Celcuity; and (v) all executive officers
and directors as a group. Unless otherwise noted, each person or group identified possesses sole voting and investment power with
respect to such shares and the business address of each person is c/o Celcuity Inc., 16305 36<SUP>th</SUP> Avenue North, Suite
100, Minneapolis, MN 55446.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Name of Beneficial Owner</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Amount and Nature of </B><BR> <B>Beneficial Ownership&nbsp;<SUP>(1)</SUP></B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Percent of Class<SUP>(2)</SUP></B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; font-style: italic">5% Stockholders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; text-align: left">The Globe Resources Group, LLC<SUP>(3)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">680,556</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">6.7</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left">Officers and Directors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Maureen Cronin</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,821</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">David F. Dalvey<SUP>(4)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">261,401</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Vicky Hahne</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,225</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Lance G. Laing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,270,235</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.4</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Richard J. Nigon<SUP>(5)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">144,847</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.4</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Brian F. Sullivan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,785,494</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27.2</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All directors and executive officers as a group (6 individuals)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,489,023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43.5</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">* less than 1%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>The beneficial ownership reported in the table includes shares of common stock the beneficial owners have the right to acquire
within 60 days of March 18, 2019 upon the exercise of stock options or warrants as follows: Mr. Dalvey, 11,401 shares; Ms. Hahne,
17,187 shares; Dr. Laing, 20,235 shares; Mr. Nigon, 34,269 shares; Mr. Sullivan, 29,720 shares; and all Directors and Executive
Officers as a Group, 112,812 shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Calculated based on 10,209,115 issued and outstanding shares of Celcuity common stock as of March 18, 2019, plus, for each
individual, any securities that such individual has the right to acquire within 60 days of March 18, 2019.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>The address of The Glove Resources Group, LLC is 8301 E. 21<SUP>st</SUP> Street North, Suite 420, Wichita, KS 67206.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(4)</TD><TD>Mr. Dalvey&rsquo;s beneficial ownership includes 250,000 shares of common stock owned by Brightstone Venture Capital Fund,
LP, of which Mr. Dalvey is the General Partner.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(5)</TD><TD>Mr.&nbsp;Nigon&rsquo;s beneficial ownership includes 20,300&nbsp;shares of common stock held as trustee of a trust for certain
family members. Mr.&nbsp;Nigon disclaims beneficial ownership of such shares.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section 16(a) Beneficial Ownership Reporting Compliance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 16(a) of the Exchange Act requires
the Company&rsquo;s officers, directors and persons considered to be beneficial owners of more than ten percent of a registered
class of the Company&rsquo;s equity securities to file reports of ownership and changes in ownership with the SEC and Nasdaq. Officers,
directors and greater-than-ten-percent stockholders are required by SEC regulations to furnish the Company with copies of all Section
16(a) forms they file. Based solely on a review of the copies of such forms furnished to the Company, or written representations
that no applicable filings were required, the Company believes that all such filings were filed on a timely basis for the fiscal
year 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; color: blue">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXECUTIVE OFFICERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table identifies our current
executive officers, the positions they hold, and their current age. Our executive officers are appointed by our Board of Directors
to hold office until their successors are elected or their earlier death, resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; color: blue">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse; margin-left: 0.5in">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; border-bottom: Black 1pt solid"><B>Name</B></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 5%; border-bottom: Black 1pt solid; text-align: center"><B>Age</B></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 73%; border-bottom: Black 1pt solid; text-align: center"><B>Positions</B></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="color: black">Brian F. Sullivan</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="color: black">57</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 6.25pt; text-indent: -6.25pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 6.25pt; text-indent: -6.25pt"><FONT STYLE="color: black">Chairman of the Board and Chief Executive Officer</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="color: black">Lance G. Laing</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="color: black">57</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 6.25pt; text-indent: -6.25pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 6.25pt; text-indent: -6.25pt"><FONT STYLE="color: black">Chief Science Officer, Vice President, Secretary and Director</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="color: black">Vicky Hahne</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="color: black">53</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 6.25pt; text-indent: -6.25pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 6.25pt; text-indent: -6.25pt"><FONT STYLE="color: black">Chief Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For biographical information about Mr. Sullivan
and Dr. Laing, please refer to Proposal 1 entitled &ldquo;Election of Directors.&rdquo; Biographical information about Ms. Hahne
is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Vicky Hahne, Chief Financial Officer</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Ms. Hahne joined as our Chief Financial
Officer in July 2017. She has more than 20 years of financial leadership experience, including the most recent 10 years in the
healthcare industry. Prior to joining Celcuity, Ms. Hahne served as Controller of Respiratory Technologies Inc., a medical device
manufacturer, from 2015 to 2017. While at Respiratory Technologies, she played a key role in the due diligence process to sell
the company to Koninklijke Philips. In 2014, she served as Controller for Ability Network Inc., a healthcare information technology
company. From 2007 to 2012, Ms. Hahne served as Controller of Sterilmed Inc., a medical device reprocessing company, where she
was significantly involved in the sale of the company to Johnson &amp; Johnson. Prior to these roles, Ms. Hahne held several senior
financial positions at SimonDelivers Inc., including Chief Financial Officer. Ms. Hahne has extensive experience in early stage,
high growth companies with responsibilities including financial controls and stewardship, financial analysis, mergers and acquisitions,
building infrastructure and systems. She received a B.S. degree in Finance and Accounting from Northern State University and received
her CPA certificate in 1990.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXECUTIVE COMPENSATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The compensation of our executive officers
is structured with the goal of providing a competitive compensation program that will enable us to attract and retain highly-qualified
executives, which is necessary to achieve our financial and strategic objectives and create long-term value for our stockholders.
Our Chief Executive Officer, Chief Science Officer, and Chief Financial Officer (collectively, our &ldquo;named executive officers&rdquo;)
are currently compensated with a base salary and milestone-based incentive pay. In addition, we have equity incentive plans and
an employee stock purchase plan, under which we grant and have granted options and other equity awards to our named executive officers,
employees, directors, consultants and independent contractors. See the &ldquo;Employee Benefit Plans&rdquo; subsection below for
additional information on these plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Milestone Incentive Pay</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We provide our named executive officers
and other senior managers the opportunity to earn incentive payments under a milestone-based incentive pay program. Payments under
the incentive program are based on our achievement of milestones that advance our core business strategy. Milestones currently
in effect are the establishment of companion diagnostic, or CDx, development programs with pharmaceutical companies. Future milestones
will be established by our Compensation Committee. Each participant is granted the opportunity to earn incentive pay up to a maximum
percentage of his or her base salary. The range of milestone-based incentive pay for each of our named executive officers is 25
- 80% of base salary. Incentive payments under the incentive program may be made entirely in the form of equity awards or partly
in cash and partly in the form of equity awards. Incentive payments ranging from 25 to 80% of base salary were made under the program
for the fiscal year 2018 to Mr. Sullivan, Dr. Laing, and Ms. Hahne. Mr. Sullivan&rsquo;s incentive payment was made entirely in
the form of an equity award in 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Employment Agreements, Severance and Change in Control Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have not entered into employment
agreements, severance agreements or change-of-control agreements with our named executive officers. Mr. Sullivan, Dr. Laing, and
Ms. Hahne have each entered into a confidentiality, assignment of inventions and non-competition agreement with us, which provides,
among other things, that the named executive officer will not engage in a competitive business or solicit our employees or consultants
for a period of 24 months after termination of employment.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Summary Compensation Table</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table summarizes the compensation
for fiscal 2018 and 2017 of Celcuity&rsquo;s named executive officers:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Name&nbsp;and&nbsp;Principal&nbsp;Position</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Salary</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Option </B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>Awards&nbsp;<SUP>(2)</SUP></B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Non-Equity <BR> Incentive Plan <BR> Compensation</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: left">Brian F. Sullivan</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 12%; text-align: center">2018</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">250,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">314,196</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">564,196</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chairman and Chief Executive Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">231,789</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">258,690</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">490,479</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Lance G. Laing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">285,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">31,145</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">94,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">411,106</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Chief Science Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">241,577</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">174,495</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">439,072</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Vicky Hahne</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">154,615</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">62,540</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">242,155</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Financial Officer <SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">67,904</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">315,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">382,904</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Ms. Hahne started with the Company as a consultant on May 17, 2017 and became full-time on July 6, 2017.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Reflects the aggregate grant date fair value of equity awards to each named executive officer during 2018, calculated in accordance
with FASB ASC Topic 718. Refer to &ldquo;Note 10 &ndash; Stock-Based Compensation&rdquo; in the audited financial statements included
in Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2018 for a discussion of the assumptions used in calculating
the award amount.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Outstanding Equity Awards at Fiscal Year End 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table lists the outstanding
equity awards held by each of our named executive officers as of December 31, 2018:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="13" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">OPTION AWARDS</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Name</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Grant <BR> Date</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of <BR> Securities <BR> Underlying <BR> Unexercised Options <BR> (#) Exercisable</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of <BR> Securities <BR> Underlying <BR> Unexercised <BR> Options (#) <BR> Unexercisable</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><SUP>&nbsp;</SUP></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option <BR> Exercise <BR> Price ($)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option <BR> Expiration <BR> Date</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: left">Brian F. Sullivan</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 12%; text-align: right">5/17/2017</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">21,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">8.40</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 12%; text-align: right">5/17/2027</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">9/19/2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,220</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">9.50</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">9/19/2027</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">8/13/2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,769</TD><TD STYLE="text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">26.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">8/13/2028</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10/17/2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,675</TD><TD STYLE="text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25.77</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10/17/2028</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Lance G. Laing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">5/17/2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,125</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">5/17/2027</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">9/19/2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,110</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">9.50</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">9/19/2027</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10/17/2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,834</TD><TD STYLE="text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25.77</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10/17/2028</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Vicky Hahne</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">5/17/2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,281</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,219</TD><TD STYLE="text-align: left"><SUP>(4)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">5/17/2027</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7/5/2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,000</TD><TD STYLE="text-align: left"><SUP>(5)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23.48</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7/05/2028</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10/17/2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">932</TD><TD STYLE="text-align: left"><SUP>(6)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25.77</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10/17/2028</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-weight: normal">(1)</FONT></TD><TD><FONT STYLE="font-weight: normal">This option vests as to 100% of the shares on September 19, 2019.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-weight: normal">(2)</FONT></TD><TD><FONT STYLE="font-weight: normal">This option vests as to 3,668 shares on October 17, 2019 and as to 305.72 shares in 36 installments
on the 1<SUP>st</SUP> of each of month beginning November 1, 2019 and ending October 1, 2022.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-weight: normal">(3)</FONT></TD><TD><FONT STYLE="font-weight: normal">This option vests as to 458 shares on October 17, 2019 and as to 38.2 shares in 36 installments
on the 1<SUP>st</SUP> of each of month beginning November 1, 2019 and ending October 1, 2022.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-weight: normal">(4)</FONT></TD><TD><FONT STYLE="font-weight: normal">This option vests as to 781.25 shares in 31 remaining installments on the 1<SUP>st</SUP>
of each of month beginning on January 1, 2019 and ending on July 1, 2021.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-weight: normal">(5)</FONT></TD><TD><FONT STYLE="font-weight: normal">This option vests as to 750 shares on July 5, 2019 and as to 62.5 shares in 36 installments
on the 1<SUP>st</SUP> of each of month beginning August 1, 2019 and ending July 1, 2022.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-weight: normal">(6)</FONT></TD><TD><FONT STYLE="font-weight: normal">This option vests as to 233 shares on October 17, 2019 and as to 19.4 shares in 36 installments
on the 1<SUP>st</SUP> of each of month beginning November 1, 2019 and ending October 1, 2022.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employee Benefit Plans</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>2017 Stock Incentive Plan.</I> Our 2017
Stock Incentive Plan (the &ldquo;2017 Plan&rdquo;) was adopted by our Board on September&nbsp;6, 2017, became effective September
15, 2017, and was approved by our stockholders at the Company&rsquo;s annual meeting on May 10, 2018. The Company reserved a total
of 750,000 shares for issuance under the 2017 Plan. As of December 31, 2018, options to purchase 123,629 of shares were outstanding.
The number of shares reserved for issuance under the 2017 Plan will increase automatically on January 1, 2019 and each subsequent
anniversary through January 1, 2027 by the number of shares equal to 1.0% of the aggregate number of outstanding shares of the
Company&rsquo;s common stock as of the immediately preceding December 31. However, the Board may reduce the amount of the increase
in any particular year, and the Board decided that no increase would occur on January 1, 2019. The maximum permitted term of options
granted under the 2017 Plan is ten years. The 2017 Plan provides for share options, restricted stock awards, stock appreciation
rights, restricted stock units, performance awards and stock bonuses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our 2017 Plan provides that, in the event
of specified types of mergers or consolidations, a sale, lease, or other disposition of all or substantially all of our assets
or other corporate transactions, outstanding awards under our 2017 Plan may be assumed or replaced by any surviving or acquiring
corporation; the surviving or acquiring corporation may substitute similar awards for those outstanding under our 2017 Plan; outstanding
awards may be settled for the full value of such outstanding award (whether or not then vested or exercisable) in cash, cash equivalents,
or securities (or a combination thereof) of the successor entity with payment deferred until the date or dates the award would
have become exercisable or vested; or outstanding awards may be terminated for no consideration. Our Board or its Compensation
Committee has the discretion to provide that a stock award under our 2017 Plan will immediately vest as to all or any portion of
the shares subject to the stock award at the time of a corporate transaction or in the event a participant&rsquo;s service with
us or a successor entity is terminated actually or constructively within a designated period following the occurrence of the transaction.
Stock awards held by participants under our 2017 Plan will not vest automatically on such an accelerated basis unless specifically
provided in the participant&rsquo;s applicable award agreement. In the event of a corporate transaction, the vesting of all awards
granted to non-employee directors shall accelerate and such awards shall become exercisable (as applicable) in full upon the consummation
of the corporate transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>2017 Employee Stock Purchase Plan. </I>Our
2017 Employee Stock Purchase Plan (the &ldquo;ESPP&rdquo;) was adopted by our Board on September&nbsp;6, 2017 and approved by our
stockholders at the Company&rsquo;s annual meeting on May 10, 2018. The Company has reserved a total of 100,000 shares for issuance
under the ESPP. As of December 31, 2018, 17,552 shares had been issued and 82,448 remain available for issuance. The number of
shares reserved for issuance under the ESPP will increase automatically on the first day of each fiscal year beginning in 2019
by the number of shares equal to 0.5% of the total outstanding number of shares of common stock. However, the Board may reduce
the amount of the increase in any particular year, and the Board decided that no increase would occur on January 1, 2019. The ESPP
provides participating employees with an opportunity to purchase shares of the Company&rsquo;s common stock at a discount through
payroll deductions. The ESPP is available to all employees unless they are employed for less than 20 hours per week or own 5% or
more of the total combined voting power or value of the Company&rsquo;s common stock. The ESPP is administered using overlapping
24 month offering periods, referred to as an Offering Period. Each Offering Period has four six-month purchase periods. A new Offering
Period and purchase period begin every six months on May 1 and November 1 of each year. Participating employees may purchase common
stock, on a voluntary after tax-basis, at a price equal to 85% of the fair market value of a share of common stock on either the
offering date or the purchase date, whichever is lower. If the purchase date has a lower price, the employee will automatically
be placed in the Offering Period beginning immediately after the purchase date. If the Company is dissolved or liquidated, any
purchase period or Offering Period will terminate immediately prior to the dissolution or liquidation. If we sell substantially
all of our assets to another company or engage in a merger or consolidation where our stockholders will own less than 50% of shares
of stock in the resulting company, the ESPP will either be assumed by the successor entity or a new purchase date will be set before
the transaction is completed, after which the ESPP will terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9.9pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>2012 Equity Incentive Plan</I>. Prior
to adopting the 2017 Plan, our 2012 Equity Incentive Plan (the &ldquo;2012 Plan&rdquo;) was adopted by the board of governors and
approved by the members of Celcuity LLC on August&nbsp;10, 2012 and was subsequently amended on November&nbsp;12, 2012. We had
originally reserved 625,000 shares for issuance under the 2012 Plan. As of December 31, 2018, options to purchase 354,874 of these
shares were outstanding. We have ceased granting any additional awards under the 2012 Plan. However, any outstanding options granted
under the 2012 Plan will remain outstanding subject to the terms of our 2012 Plan and the related option agreements until such
outstanding options are exercised or until they terminate or expire by their terms. In the event of our merger, consolidation,
sale of substantially all assets, liquidation or dissolution or other change of control, the 2012 Plan provides that the Board
may accelerate the exercisability of awards, terminate the 2012 Plan and unexercised awards, continue the 2012 Plan with respect
to outstanding awards, replace or exchange incentive awards for similar securities of the successor, substitute the awards with
similar awards of the successor or provide for cash payment for outstanding awards (net of exercise price).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Retirement Savings Plans. </I>Celcuity
maintains an employee benefit plan qualified under Section 401(k) of the Internal Revenue Code of 1986, as amended. The Company
currently matches up to $1,000 per employee per year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; color: blue">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AUTHORIZED FOR ISSUANCE
UNDER EQUITY COMPENSATION PLANS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table summarizes equity securities
authorized for issuance under our equity compensation plans as of December 31, 2018:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Plan Category</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of<BR> securities to be<BR> issued upon<BR> exercise of<BR> outstanding<BR> options, warrants<BR> and rights (a)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted<BR> average exercise<BR> price of<BR> outstanding<BR> options, warrants<BR> and rights (b)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Number of securities</B><BR> <B>remaining available for</B><BR> <B>future issuance under</B><BR> <B>equity compensation</B><BR> <B>plans (excluding</B><BR> <B>securities reflected in</B><BR> <B>column (a)) (c)</B><SUP>(1)(2)</SUP></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; text-align: left">Equity compensation plans approved by stockholders</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">478,503</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">9.73</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">700,998</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Equity compensation plans not approved by stockholders</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">478,503</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9.73</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">700,998</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Includes 618,550 shares of common stock available for issuance under the 2017 Plan and 82,448 shares of common stock available
for issuance under the ESPP as of December 31, 2018.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Warrants to purchase 353,980 shares of Company common stock also remain outstanding. These warrants were not issued as part
of an equity compensation plan and are not reflected in this table. &nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Transactions with Cedar Point Capital</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mr. Nigon, a member of our Board, is a broker
with Cedar Point Capital, LLC, or Cedar Point. Since January&nbsp;1, 2017, we have (1) paid Cedar Point $818,750 in cash as placement
agent commissions in connection with the private placement of an aggregate $8,337,500 of our unsecured convertible promissory notes,
and (2) in connection with such private placement, issued to Cedar Point warrants to purchase an aggregate 48,615 of our common
shares with an exercise price of $8.42 per share. Mr.&nbsp;Nigon is a Senior Vice President of Cedar Point, but is not a director,
executive officer or equity owner of Cedar Point.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Sale of Unsecured Convertible Promissory Notes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Since January&nbsp;1, 2017, Mr. Nigon, a
member of our Board, and his immediate family members purchased our unsecured convertible promissory notes in the aggregate principal
amount of $775,478. These notes converted into 82,030 shares of common stock in connection with the Company&rsquo;s initial public
offering on September 19, 2017, and Mr. Nigon and his immediately family members received warrants to purchase an aggregate of
12,246 shares of our common stock in connection with conversion of such notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Indemnification Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have entered into indemnification agreements
with each of our directors and executive officers. These agreements, among other things, require us to indemnify our directors
and executive officers for certain expenses, including attorneys&rsquo; fees, judgments, penalties, fines and settlement amounts
actually incurred by these individuals in any action or proceeding arising out of their service to us or any of our subsidiaries
or any other company or enterprise to which these individuals provide services at our request. Subject to certain limitations,
our indemnification agreements also require us to advance expenses incurred by our directors and officers for the defense of any
action for which indemnification is required or permitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Policies and Procedures for Related Party Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have a written related person transactions
policy that our executive officers, directors, nominees for election as a director, beneficial owners of more than 5% of our common
stock, and any members of the immediate family of and any entity affiliated with any of the foregoing persons, are not permitted
to enter into a material related person transaction with us without the review and approval of our Audit Committee, or a committee
composed solely of independent directors in the event it is inappropriate for our Audit Committee to review such transaction due
to a conflict of interest. The policy provides that any request for us to enter into a transaction with an executive officer, director,
nominee for election as a director, beneficial owner of more than 5% of our common stock or with any of their immediate family
members or affiliates in which the amount involved exceeds $120,000 will be presented to our Audit Committee for review, consideration
and approval. In approving or rejecting any such proposal, our Audit Committee will consider the relevant facts and circumstances
available and deemed relevant to the Audit Committee, including, but not limited to, whether the transaction is on terms no less
favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent
of the related person&rsquo;s interest in the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Prior to the formation of our Audit Committee,
we did not have a written policy for the review and approval of transactions with related persons. However, our Board has historically
reviewed and approved any transaction where a director or officer had a financial interest, including the transactions described
above. Prior to approving such a transaction, the material facts as to a director&rsquo;s or officer&rsquo;s relationship or interest
in the agreement or transaction were disclosed to our Board. Our Board took this information into account when evaluating the transaction
and in determining whether such transaction was fair to the company and in the best interest of all of our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9.9pt; color: blue">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AUDIT COMMITTEE REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Management is responsible for Celcuity's
financial reporting process, including the system of internal controls, and for preparing Celcuity's financial statements in accordance
with accounting principles generally accepted in the United States of America. Our independent registered public accounting firm
is responsible for auditing those financial statements and expressing an opinion as to their conformity with accounting principles
generally accepted in the United States of America. The Audit Committee's responsibility is to monitor and review these processes.
The members of the Audit Committee rely, without independent verification, on the information provided to them and on the representations
made by Celcuity's management and the independent registered public accounting firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During 2018, the Audit Committee, consisting
of Richard J. Nigon (chairman), Maureen Cronin, and David F. Dalvey, held five meetings. The meetings were designed to, among other
things, facilitate and encourage communication among the Audit Committee, management and Celcuity's independent registered public
accounting firm, Boulay PLLP (&ldquo;Boulay&rdquo;). The Audit Committee discussed with Boulay the overall scope and plans for
its 2018 audit. The Audit Committee met with Boulay, with and without management present, to discuss the results of its examinations
and its evaluations of Celcuity's system of internal controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">During the meetings held in 2018, the Audit
Committee reviewed and discussed, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-indent: -13.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: left">Celcuity&rsquo;s financial statements, its Quarterly
Reports on Form 10-Q, and any reports received from the independent registered public accounting firm;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-indent: -13.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">recent accounting pronouncements and the Company&rsquo;s
significant accounting policies;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-indent: -13.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">disclosure controls and procedures and internal controls
over financial reporting; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-indent: -13.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">engagement of Celcuity&rsquo;s independent registered
public accounting firm.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In February 2019, the Audit Committee reviewed
and discussed the 2018 audited financial statements and notes to the financial statements proposed for inclusion in the Company's
Annual Report on Form 10-K for the fiscal year ended December 31, 2018 with management and Boulay, including a discussion of the
application of accounting principles generally accepted in the United States, the reasonableness of significant judgments, and
the clarity of disclosures in the financial statements. The Audit Committee also has discussed with our independent registered
public accounting firm the firm's independence from management, including whether the provision of non-audit services is compatible
with maintaining the firm's independence, and matters required to be discussed by the Statement on Auditing Standards No. 1301,
as amended (Communications with Audit Committees). The Audit Committee received the written disclosures and the letter from the
independent registered public accounting firm required by the Public Company Accounting Oversight Board regarding such firm&rsquo;s
communications with the Audit Committee concerning independence, and has discussed with such firm its independence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on this review and prior discussions
with management and the independent registered public accounting firm, the Audit Committee recommended to the Board that Celcuity&rsquo;s
audited financial statements be included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2018 as filed
with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Audit Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Richard J. Nigon (chairman)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Maureen Cronin</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">David F. Dalvey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">STOCKHOLDER PROPOSALS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any stockholder desiring to submit a proposal
for action by the stockholders at our next annual meeting, which will be our 2020 annual meeting, must satisfy the requirements
set for in the advance notice provision under our bylaws. To be timely submitted for our 2020 annual meeting, any such proposal
must be delivered in writing to our Corporate Secretary at the principal executive offices of the Company between the close of
business on January&nbsp;17, 2020 and the close of business on February&nbsp;16, 2020. If the date of the 2020 annual meeting is
advanced more than 30 days prior to or delayed by more than 60 days after the first anniversary of the 2019 Annual Meeting, notice
by the stockholder must be delivered not earlier than the close of business on the 120<SUP>th</SUP> day prior to the 2020 annual
meeting and not later than the close of business on the later of the 90th day prior to the 2020 annual meeting or, if the first
public announcement of the date of the 2020 annual meeting is less than 100 days prior to the date of the 2020 annual meeting,
the 10<SUP>th</SUP> day following the day on which public announcement of the date of the 2020 annual meeting is first made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding the foregoing, if the number
of directors to be elected to our Board is increased and no public announcement naming all of the nominees for director or specifying
the size of the increased Board is made by the Company at least 100 days prior to the first anniversary of the 2019 Annual Meeting,
a stockholder&rsquo;s notice will be considered timely, but only with respect to nominees for any new positions created by such
increase, if the stockholder delivers such notice to our Corporate Secretary at the principal executive offices of the Company
not later than the close of business on the 10<SUP>th</SUP> day following the day on which a public announcement naming all of
the nominees for director or specifying the size of the increased Board is first made by the Company. Notice sent to the Company
must comply with the requirements set forth in the Company&rsquo;s bylaws. You are advised to review the Company&rsquo;s bylaws,
and due to the complexity of the respective rights of the stockholders and the Company in this area, you are advised to consult
with your legal counsel with respect to such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, any stockholder proposal intended
to be included in the proxy statement for the 2020 annual meeting must also satisfy Rule&nbsp;14a-8 of the Exchange Act and be
received no later than December 5, 2019. If the date of the 2020 annual meeting is moved by more than 30&nbsp;days from the first
anniversary of the 2019 Annual Meeting, then notice must be received within a reasonable time before we begin to print and send
proxy materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.45in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">By Order of the Board of Directors:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Brian F. Sullivan</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Chairman of the Board of Directors and Chief Executive Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: April 3, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: blue">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY
OF PROXY MATERIALS FOR THE 2019</B><BR>
<B>ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MAY 16, 2019.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Notice, this Proxy Statement, and the Annual Report on
Form&nbsp;10-K are available at http://proxyvote.com and on the Investor Relations section of Celcuity&rsquo;s website at http://www.celcuity.com/home/investors/.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="image_002.gif" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<FONT STYLE="font-size: 1pt; color: White">CELCUITY INC.
16305 36TH AVENUE NORTH SUITE 100 MINNEAPOLIS, MN 55446 VOTE BY INTERNET - www.proxyvote.com Use the Internet to transmit your
voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the cut-off date
or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records
and to create an electronic voting instruction form. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your
voting instructions up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in
hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid
envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK
BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY THIS PROXY
CARD IS VALID ONLY WHEN SIGNED AND DATED. For All Withhold All For All Except To withhold authority to vote for any individual
nominee (s), mark &ldquo;For All Except&rdquo; and write the number (s) of the nominee (s) on the line below. The Board of Directors
recommends you vote FOR the following: &bull; &bull; &bull; 1. Elect five directors Nominees 01) Maureen Cronin 02) David F. Dalvey
03) Lance G. Laing 04) Richard J. Nigon 05) Brian F. Sullivan The Board of Directors recommends you vote FOR proposals 2 and 3.
For Against Abstain 2. Ratify the appointment of Boulay LLP as our independent registered public accounting firm for the fiscal
year ending December 31, 2019. &bull; &bull; &bull; 3. Approve, by a non-binding and advisory vote, compensation of the named
executive officers. &bull; &bull; &bull; NOTE: In their discretion, the proxies are authorized to vote on such other business
as may properly come before the meeting or any adjournment thereof. Please sign exactly as your name (s) appear (s) hereon. When
signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign
personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized
officer. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date 0000406354_1 R1.0.1.18</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<IMG SRC="tv516969_proxy2.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 1pt; color: White">Important Notice
Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice &amp; Proxy Statement and Annual Report are available
at www.proxyvote.com CELCUITY INC. Annual Meeting of Stockholders May 16, 2019 2:00 PM CDT This proxy is solicited by the Board
of Directors The stockholder(s) hereby appoint(s) Brian F. Sullivan and Vicky M. Hahne, or either of them, as proxies, each with
the power to appoint (his/her) substitute, and hereby authorizes them to represent and to vote, as designated on the reverse side
of this ballot, all of the shares of Common stock of CELCUITY INC. that the stockholder(s) is/are entitled to vote at the Annual
Meeting of Stockholder to be held at 2:00 PM CDT on May 16, 2019, at Celcuity Inc., 16305 36th Avenue North, Suite 100, Minneapolis,
MN 55446, and any adjournment or postponement thereof. This proxy, when properly executed, will be voted in the manner directed
herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors' recommendations. Continued
and to be signed on reverse side 0000406354_2 R1.0.1.18</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.gif
M1TE&.#EA+ ,<!/<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M?6)<2['_-:<@[NU>,BGKN]SC=14QWB?W%<R=!Q=$L0D2P;=R+U)0EG)72PJ
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MI8=,BL9$5+9+Y.=<O ,-)94 K$!TES0\/+4"*]526S8O\40D\]1'O31)6,"
M9%)-:X<P_810"2AU* -V4')B+%!6;$4H*<4X$8-T"&AUTQ(QNC)3XU1.<X<P
MZ&-0JQ,([:0H;B<F()8DT^.$/"4P.VAY:0A/82B IE%<OR4IR58H4;@II;5#
MAS Q#A9HBH1;$=9=%WATOA5^'4@*4?^8AWH5;2C#3-F'3%62 U9038Q8>SKE
M*P6F32\&A"ET+)73,I9"<'JE7* %=8,3;H" !7]X6J,F6*UD6#J@!^O5!;)'
M:]/C",T%.IU2*$&R"N>F5PBPA[#%-*A69(/65VPUBRSH7*?E;8DE-Q+E*3,@
M> .!6%<27KZH6,M8*=>(/?9EAZAA=([8"4TV!LQ&6+OV!#) 5(38!8&&3.V8
M?<-W=%%V:_GHB&L6B2$838I2B<JW43#82J^DCIYP"'!6@P2!9@##<:5B8F*B
M:ZMF;,XDA##W84C2-WF&9#-#8U.2!Q Y/Y F:=+F,"0C86(F5)S(8?C'D2$6
M3*:F6!&S9Z3_< 7:J'[?5Y(3N6'JAV4I9H[G&)!'AXPGJ&<Q=P42DRWS:(A\
MN&8(4U:0]HB,6"C/)BG_&%TG.(D#:7IL92>86%("\ <.^7]H,PO'$$SJMR1M
M!38'0P-O0G BMES2%(2ON)&\EG6M6%&X&$<2=25Z\):-<G 2M(C$B'''F'"Q
MA6J@%I-[J4R5$W.",&S5N(WXE24[>5^"29@3Z9B8Z2F_1Y2D@8X2YG/#IY0L
MACZ!H'!2,X$&TX^7M#X]U4ZN1YLG>'04%Y!>>8$P%5(%0XK[AX)\-3MMU)6<
M: W2HE\&V'H;)W%6UV5WF9%Y^8X7-Q H1V(AQU5.2";Z%5%=U&F)_Y O$B=X
M54=+DH<P%+=J<K=/.2)U.0<ETC.'S[:9;L=TWHD(X[*#!$2?HTF:U$&0CM%X
M +HG LIXD>)Y!;J@#-J@'#%'BI1_C500<Z00Q<261K%Y$<I+TA1_P1<Y](<3
M<W2@#T&BSI<'T><0\N>@J6%]#;%YSC=X,>IJ20&C"'%\#;&BJQ*B-P%+)MH0
M/WJ6$J&C+%H9XFDDLV Z3&A.D/(D'N530Z<K=0=6$/@D1_B8NO2 LZ515XJ5
MH?5V.P8I&/6%:H)4$#,MX3<#K>D^;;53F;(";S@D$^55T_.D##,]7_A#+K=#
M4.J$M24\(/,,$>A4'8=3.\4T#F9RN6EZ//]5 EM53U8X+][B@"O5A>NC@1$W
M+W\Z* ]P#)/B+E5(=TXR+F88AURUI^GT<'Y:I)DAC)#V/7]9B(%E"'JE2+V5
MA\Z&7 &6E0,QB. RJ\H$,CLC$ GP);8%C;J"7L4Z-O;F9\PE:T8V-;^8<,_F
M526@K,'X7[W(7?PB8'5ZJ\"%IWZE*(G:7>#5C<0:7,BF _H#7,XF6+!X6.!7
M5CK@";'6==)62]LE7Z6 ",^5<IV 7;R32H,FC,!5C)7BKNNZD/"UB$3'*!Q8
M2.#(6"WT)=:5!]QX;JR*&</W2Q:%)F%B)*<2=%BV@AM$: $0CYD2:+@C/9.F
M2R6@LD$SLRVK*"?_&;"$TF=ARFZR9%%V]$LPU4 W^[("49* -6CY:JM2B8+,
M);.+ZDS?-Y6!P&QD<+0E6R;4B*=[$ M0L$LT@*^56)*"<$$LN&'Q<E7E.6G]
M")1Z,[6D0 9G$B?X>GQ1!"4EQK8I2R9?0F)0^Z$;.QD=BU]_2:Q\R5<D2PJY
M^F#]!FG/Y@R!MJL'<:&&P)2->UG(!KF<YT[C&&G]IS'L!EKN94<)]SU=1RR/
M@'"F8YM@<[00!FG?NK1V2;G9\K2GHK'=0T2+ZFPB1EC8F2GD92M;RZM%1YB!
M8#JL8#\"]:'E5UMJ6V[*6P;> [TK &_"R(BKH@JI-;'_UY1[2UB!J;%__VND
M4>:Q.Y1V<,I$7B.!]YAE(T5T7>6(K.F:3T@SS"2YG[JF$>14[@E!3$.?F/)T
M[86& D6_*W9S6F5W>?)WO;N#^C6W=?>Z2;MJ]K(^"N=UJPI!FC)[BZJ_>3"4
MOU<Y7#(YWT6;E[1UXQ*;4J=E<G<-\-MZZ@FV=E>'LW=82BHF,J"!_;FGW_><
M85A/K4F-]_EIX>L::;IX*T&@Z]>AD02M2X&50XPAZ=D2E:>@-ZK$"3'%3*$C
M?OO$7-S%7OS%8/P2:R(WE<:C@B1^"F&C!A%("\%'1*H0;'S%TA3'5A)Z4FS'
M[6=*%8H1=#P1.&H0*4JA>+P0?_3&83P9=229[/]HQA0*1T&*2X-UQ</Y$!@J
M1W(6R32QH1&AR2XZ$94L$7]<2Y.L$9]\R)9!5$9%O\QVGFC#J4PC).N$J=^E
MJ47WBCCE+:0 )CC3.89B<4_53JDUAU4U4 6%3Y)RIVTH)L/,PF B*0#U!%EE
M5=[DI8TP53R(9$AU/5LHJ6,HS-DL,,]P"$]0J26L++<\"^%L)VWR)(&W*F,8
M3_^41"=VA4PHAM,BS:<:5E$GSRS53NS$PF:6JNZT2)!ZJ*QE<LW,4/@L).4R
M>:9,>>E67NO&;-PV9.IJ-)3FR.9*L;4<K]>579:%7G;I7\_&9H4TCOKE5Z+%
M@3 ;:[2%TOOE9=OH"='_/*Y&!CH0DYE^R<3VM8R?]:_X]9WM=FV&>!#%ZM%_
M>6V* DO4"F[3:#6YZ&Z.8 6[%=4%4:^KJ"@^S6KP)5]LAI6;:XL2>&"GQ3.J
M<*UZ$&NA^ #B!%F2!9<//:!OYK5)QFSK2%9NZX*VM+8DLR1Y268^I%LE<)$?
MAF=P)+$YZZP\MD_'Z;4BR6=^)EMN=&,YEE47N5.1AK-2YL$[5Y<I9#B]!-E(
MP$K,E;96HK+=:U%N='RPM(ZZ,UAY-&<DF694C71,U$DX]CB7S8F'9F=LJ%E8
M%MJY3&*4)9D:4\UT[49L+<&K/<IQC1CB];OFM<@5'0M$1$2MM+8?JI&\:V14
M_SW8*X9>1*UOAXVQ0:W8 _FPN^72-134,5UGNW6N7D#3 7Q\!Z=-^$4TP];9
MO.N8DVDKR-:L*U:8K-@E>\6]G$W@2XV,NI)M+@EOX@8VWPUOEU1KEPU!X<75
MQ$K>01)E84W<3Y!M6LT*VJ+6REUQ7 W7S[T88B?"9>QS&$S#$Q,EZPM6!,3=
M>81UL>-H3@7 :P<U/Z7,[+FG)'?,[BG,XR1%6?(CU679'[>-_6MF.<??Z F=
MGQKD/R1+#'T(+:9T8DC!U+CE RDU[?SE(_:>RIR?"N3,M*QR+(>&?1=UROSC
MZ[2/ 4W<^TQSW\)/2LY0%\G0_KKB!(+$I5%'05+@@O\.(%B<&M>9Z([^Z,*A
MQ@71QV<LZ0:!2E0,Z9J>QIC<3 YM+?:WZ:)>RRC%, +#S$XG+P(7IM:C@U
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M*V]IHHIZH\&:L'-.2G62?^K>M>>SCUE(EVX"F2B$<RJ7HAE0:DAY_??GOZH
M[G_&C)SQ&,. :!220T\>8K8^DS1"2EZP!JLX=KC^5=""%\1@!O\UN$&((4!%
M+&#. 4W$)^SHJB"PFE<.9O&E&9""!23R0AZ Q4$:UM"&-\1A#FLXF%4\02R1
M 8T7;#(2V5#&*%X!RPF-U0@6J"6).H1B%*4X12I6,5+_B\439/2S !BQBP1A
M$<A DJ OTBA"%K)B&I$F@$Z-Y"5:6<%3 C &S($DCE(Y@'_@0T>E(( 4_HL+
M4O*8E0>0*I"F"8 *! "(IBQR*7=D2AX+*:!$+I(%?\P>'QV"R1PA1"82": :
MC_?% "#+5U3R3ZN<5;X16BN&H&+!LD0YRVFQ\8%OQ(HMG3+'.NH2*@9Y(R_[
MR$FI/.!AP-R*,5&CS*SX4BG('! S_1C_D@-XX4K#,5M+\H< !_E1C[1\W/WH
M<A#,G 1]MZ$( !;HK0;ZQU8;$R,XY;DD71KD"3&K2?U2Z9/?T( 5 (."6K[(
M)Z&P '^\G.,38K(",@A"*/Z9E7 .2H9_VH^!)_G-01)%QY[0I:$_8<$J/D:J
M1#S4G\_K:/[:DI*8-8\H#KW&/X52 HH*904E=09#!6$-/7SL/D#JF$ E4U)D
MK("."76+<V UF)[:M P\!00+6''0CPF">E&=:DH,*C*Z):.DT*A-0F,B@UG4
MB:0VK6FB\#G$:?H1"Z5882K_Z-9__N:I>H@J)P]@5-NLX)(%H2,^95@29\[3
ML(=%[(#JZ87D_PPQ0:DRRH1H(*$\P.IG &!C"?0RF#D<=0Q6<- ,2K&@+NHF
MLYLEPQS(0*I&-(9+;;3G8STQ!F4)I@LE(A49KE S'85ILI/-C!Y:UH6/&/-G
MJ@0F#?I2$$?@MHM,D])J#;6I&>2!F<5*P#-\FXQ#("&A*,P5VV)A53[A*V51
MY>V.2!4FS*)W1CL""F8-05-B>1:T,R&%%_:BP)<E@[22L8])YDH*+%#$A)O<
M9($S8]WS_C63NIGF'@F2 RNPRD&)Q7"&-;R57DF)CN+4 T>$ I(#6*&D4-J,
M#)%!!NH9@@5MI($>/'N%XB!T#%# B1Y<#&,9>W<,5VC1E>PI8N[BN/\C/>93
M( :LWP1O9C^T HDQ(2O,Y#:$!7T3GV?#]ALZVM*/U66FLUC,9 0 QL=:7)D9
MGR&(Q) B599<,D&8">=-LH"H+RZ!9WU,8S#ME\QFYJ4XMSE@+) )DVTE<(J-
M2><'%XJ8(9G!>-)VX0T?[4D+<8(Y#TB2A'*:M@L<B-S>8Z]K.(><:#08^OXW
MBU"RDFT^B1$NT28=$)FZQNR]W\@JO</4,BN5JQ!$_L"T7A3S"6'-.ZU@4@NK
MPT"WS-T5IGPUJ^S.[EG78+JG2FDKR\&0ZL=+?ADR:.!D68;$N#)!KG['W:M,
M-U?/N9HM$KSL9@:'I">_F1"?5KQ$-&?/$3#_RK=RWYS73<8P:W2.\&"L,-^C
M,KNUZ,[O?@/.71]#^,*M I6"(>OKC"NZP<2,=H0+T@C;4-A! OC#KBW]"/_B
MSH1-@DXC5O"(F-.W4(^X4H9BJ)E2E@A:!_8@"4#X3)8CPI,O_*9#*+WQEM3D
M+#9)@&.(J_(:>NQYY1HG U<B"'&G6)W+191!;W6-9)!H)6B.=M@/JF6:"%L@
M6X8"1]/$4%9H=< E("K04GRN=/JII2^92[#+Y=]JS]'(0NIRI[Z\-V&3)P!Y
METC9^QT2Y@DF[P_!ZU_]B'=KD+>]FG>S]=A#\>Y)WB4"N<)9BZKE@Q1E7(%
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MDM[-X"I9:9SO'M>(R+DF.4]\(4A^U()K'&,&J!O-)P,Q![/L[B5[K(C@A :
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M\1 ]^6=1*KK/Z0\'_)6/:9C1P"<:EG^ XB>>15FP@/:ZAF&]A:ZT^JE/^D/
MX@P\@R 4B42,@K"_]PRX:8=WJ[U8_*B[[IR^!L(_A,.W8\0/B:G+B\E?NEE:
MB<)[P<JSQLAGO+:TA:U/?&*0 <B3^FO@1SVZB<+GA]!+)$;8.FR\/,0S_'F[
MJ0Q4 <@$N]'3N,I'<LTS;]!;_,ZW:-?7?%;B_-;G_-C[QIPTLOV>JO^*K@X8
MRB';]="CZQS__#4T\I66:2"8JFWSZK:N\1S$:[V3[EJ0,4R8<9^F<2(/\AXK
M_SX?YSU@JS%7;(RYV"H.'WS"#WNNO\4G"D!-D$+,WPB8'X#."[L>7,%4!("D
MTP#<"[I9R (K?"482_K97\%1W<OJ3X7-C_Q[MWR8C'[ILX:8X-3=,KSN?_E7
M"?_$ __1OWXU5&I_AKV!) #MVWYPZD!?@'SRO'J:OWJL?Q9:4(4,MX;H6P/I
MGSVUX#Y15W]?#/OX_SY8P ;"+S\WPC_]]^CS/[VVN"G5'SI D+)BQ0D"64X
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M7Y+P5F'N]R>R?>#. *%7J.%GU4_<;<H?39@^!&"UXOV+L-\0[N>[%4Q+N1Z
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M[=R[3\<^T[KW\>3+FS^_&CQ,]>C;NW\//SY+]I=SRK^//[_^_17_Z;?TSU^
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M1V:!UA59/3'E5  [5_3 -4)NE-51.%-$ U'6T%E1M5PWU 4K7X>6])!,#93
M014) (A*,ZRRRM@4/:!VUVB1ME3<6!V4=M=>?#E*6CQ-1+='A1,[N$4/'%/0
M0'2!EO= .DB=1_\ .<B-Y*5V\ZP1AT0E'M8LUDJ$@" _%83(X%4#>W)>  9
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MF8JU L$L:X.22;EJ<_^D1QF#J009B+@Z-WV12>A1DM>_W9(.$7(A']VJ=MI
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MC#JR;4(W1(<@"%M#)#/",]E(C%/CB4,"C2SX#"XD(U^B$$5R)&3 "M22+*V
M3HE@CA.A XK2)@5!BZZ"A]48  $)CB%H%$02C'Z($(+B"8/(@:13)>0HCN0(
MC:U(8.!8CL8X-89(;"?(,!6DB V!".;8(S\"$;/ "B5).DD(B8X1-:T$ABN
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M/L,F6;G_H'PX$0Z**(LBG[;B@"BTABYR*H,J!X[*H2F*3F9B/<B)EU*ZER5
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M31%,&C,G!O=B28)ZTXL:W6A7S/BHHY1%)67D5$G0^$,Y!0 1[:$F? H5&L#
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M+4>K:]W&D312FNJ36;)[W8>PH%Y#A=2_<E+>Q:5U(3?R3RQO0Q-#-O2[7 F
MN+:XI/K*%V1Y&Q9'0YI?EUCMOXDK;X %;&#K>K2+"3XP G:COT<E(%0ZB7!
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M9X5VN_=[1[<EDS<RL[=R5Q=]U[=#[+=T_W=JP[<ZRS=6^/> UW:!5W)^'W.
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M'FI4Z@B*>>8L<8809*!+664.DQ%RI+D-?1,Q7H8=AEABC#76E^NNS6IYX,J
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'$YM[# @ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tv516969_proxy2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv516969_proxy2.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@$)0,T P$1  (1 0,1 ?_$ ,$  0 !! ,! 0
M       (!@<)"@($!0$# 0$  04! 0              ! $" P4&!P@0   &
M P ! @,""@@"!@< $P #! 4&!P$"" D1$B$3%!4*,2*4%E:6UA=8V$%1M#5V
MMWDZ(QAA,B28&5GP<8&1H4(S);'1)L%#-#;Q4F)$5&:F.$BX.1$!  (" 0,#
M @0$!@$%      $" P0%$1(&(1,',11!42((@4(C)&%Q,A46%U*AT?$S0__:
M  P# 0 "$0,1 #\ W^
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MEEIUJ0\PXC*DG0E049N:FQO@O*DK73?.3$^#,^WWX]=?=\/7U =L
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MQCFE]@]W+_O!]]6I(+.0+F?$J9_'C/ZXL1 A5'*$TF,1XJ)U?US;A6SIL?\
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MYB$U&ESOE;C?;0K<-@@
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M&T1%SDJ>QV_]Z2(UZI=3="6VL4*9&-7-1RZF*3_FHIGVKY@HF;[X:?H-L_\
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M<]3-##L;:&YU")JGRDR:OJ)M/I"].;4+134-YXEG0D-M#G2]V'JNM)3^:YS
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M6#(8M%FR2.2B2(:92J#+&::\>R6+>-6,]0UP3Y1O*=A5N1K(H]^%^J?!1N=
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M-?-2TWM7]5.D=>ZG=7-R.C@KEOER5BN&:Q?\>V;1$Q$Q'KUF)B?3_P!WMO\
MU%S[&%EC-SY:\21.%20^!SZQD&%IBM;%8?:"QV;J]?5R5"2I//2S!<QJ2D.I
M&IQIV^FN,:^IA?O@<=\5?(W*X.+V=#A]W)K<UN[>GI7[.VNQLZ%<=]W%6UIK
M$6UJ9:6S3>:UI$S,S^F_;=?>U*3>MLE8MCK6UH_*MNL5G^/2>G_P\:^>P>:N
M85T?;+XMF/URY2IFD,CCS>ZI7M<N=(]$3V<B6OJ=(R-3H?AFBFK\E/=%6VNI
M#>CWV4J-BTY1IND_X\^%_E'Y7U]C;^/>&V>3U-3-APYKX[8J4QYMF,DZ^&UL
MN3''N['M9*8,<3-\V6(Q8XMEO2EK=OD=+1M%=O)6EK1,Q$]?6(Z=9](GTCK'
M6?PCUGT?@Z=E\OLL\<ZU<[FB*:6L=<:W!("/F+SV.-529'726)K&E$P3H3H=
M&86NCS(K4IG%>O3I56J8S4K???7.HOU/A/Y7WO'<7E6KP6]?AMCE/]MPSTI&
M7/R$9L>O;2P:TWC9S[5,V7'2^'#AODQS>LWK6L]2W):-,LX+9:QDBG?/Y13I
M,]TS](KTB>DS/2>GHZ%;=N<L6[M&BJ^N!C>U,NFI]<,B%2UR:/N.\[+ARFPD
MD4<VV2LC.OC[T_05&<[M!+@6ER]-Q6YZ#ZDO7;;$CRKX)^6O"HVK>2\)L8,6
MEH1NY;5O@S4C4G9KIVV*7P9<M,V+#MVKK;-L-LD:N:U<>S[5IB%N#E-#8[?9
MRQ,VOVQ]8GNZ=W28F(Z3-?6.O3NCUCJ]9N["YF=XG-)XW7%$U4-KZ!8M.5R7
M0Q=JSH:WW?IQ%TTY0K#46A3_ !=>_P!;O:5*L;LJR%9B#;Y.QFIA.3(>U\,_
M*>ES.AX]M<)NTYSDN1^PU\$Q7W+;T8=3/;4O6+3.'8IAWM7)DQ9O;MCKECOB
MLUO%;J\CHVQVS5R5G%2G?,_AV];1W1^<=:VB)CKUZ>GX*E0](T<Y1J%2Y'8[
M%O'[$G[Y5<.7&87IMWBQ(P?,$\GB&$*I&2XH'J,F5^^9<BE11'T&C4IW/R7H
M3OMC6;'QEY[J\GO\/GXO9CD>,X[%O[-([+>UI9XUIP;/=6TTOBSQN:OL6QVM
M[L[&*N/NM>(7QNZLTKDB\=E[S6O^-HZ]8]?7K';;KU^G2>OT1&L'RO\ &,2K
M979D5L]-9[4VVA2U;.:&&,LO7.29/=DX31*/3](@(C"IR?:YW;R7-Q0/C<G5
MM+[]E&I&Y2H5[EEY]D\;_9_\Y\UY1C\5Y7B;\3N9>)Y/>I;:RZU*6GB]6VQG
MT[7G/7'BWHO.##EU,U\>QJ?<4S;6+'AK:\:_-S_&8\$Y\>2+UC)2L]L3U_7;
MI%OIUFOUF+1$Q;ITK,RDZFZVYQ67(FY_3VQ'-K>5XT*)AVVCH4;]K;L!<MUB
MASR<WEQU-/<Q([5V_-XQ7H^X:\_5Y2?3XR9CRK)\/?)N'PBWR-DX?:CPNGK.
MS_3F/;C-.O\ <1BB\YK:GW$3K_>UQSJ?<?T?>]W]*;'(:4[/V<9*_<S_ "^O
MUZ=>G7Z=W3U[>O=T]>G1V+IZLYVYU<(RTW9;,5KQRE^BU4R(GL]5NHV9VM0A
M2/$J=BV]*MS'(.Q*W1*2X/SE](S(#5).BA47L;IC;%X+\1_)7R;K[>UX'PVY
MR>MI36N6V*M>GNY*WMCU\<WM7W]K+7'DMAU,'N;.:N.]L>*T4M,5VM_3TIK7
M:R5I-OIU_*/K,_E6.L=;3TK'7UETL]>\U8O'3F[][\4_?3NIT;M(7@Q=G;9_
M-COYXE0_$A^B_-7\_#8=_P#9C5@^N^VMFG_MF$OTW_%&?_IOY1_X!_VC_LF[
M_P $BDW^ZZ5_^F,WVT[/L]WW'VD;/]M.Y[7VL;']#WO=_0?[AI?=?9>Y7[K_
M ,?\>G7IU^G=T]>WKW=/7IT614>4K@%/HOVVZ7A9VZ%IW?"TJ-KF+@O>VQ*K
M.1/"B(-R&-*5\WVBJE,9J^%LY:XUAP7MLXZI==<YQWV+]I?[C,LXXKXIR$1D
MS1BFUKZU*8LEJQ?%79O?/6FK]Q6U9U;;-L5=OK$:TY9F(19YWB(__>OTZ_2T
M]8_'I$1Z]/YNG7M_FZ+XV!2?)_9T&@;Y:U0T+U!72A$@G-:.-CU] K>BN4,D
M;D:]NE4./E+._-Y1+VU[$&Z*DF=?GD^S/NSC&OIX+RW%<GP/*[7!<WKYM3F=
M+8R8-C!EI;'EPYL5YIEQ9*6B+4OCO6:WK:(FMHF);/'DIEI7+BF+8[1$Q,>L
M3$^L3$_C$I M[>WM#>A:6E"C;&ML1IF]M;6],2B;V]O1$Z)D:%"C3:%)TB-(
MG*U+**+UUT+TUQKKC&,8P->O=P
M                      !&3KVDI'T+2FU:15T9&9XS;W-5AX72#=<6V?9=
M+=)5-<\@1YV;D3@J^O=(_ %25'CY?R]EAQ6#-RR\[F:!'7IWBZ=WA..OY5'Y
M#"6TGH7QMR#BZ(ZOF[QJM8YV\O%XN6LA?]D3*NU)A6=;,;_F[)MU"S.Z0W_L
M^?:7G<(L/GBTLE9TC*YGL[PR7T]:U\\^]$3/,FZ)[%B2Z"R>EHM3;.XQIBYL
MK";1CG:X\NCU23<XL$AD>[<JCYZG_MB%\*1IR=@R!W;RLDO/H* SF:D1M_IM
M!RWU3SM9$%=3731VE)/0LJYR=DOT7T:;5,6T)&BGG(I4=]6G5D*%*7=/C;.-
M]R@QVU;XY.QJ-?&FXF:VZ:OJ]:WZSNZR(8;<3A-HHR6?0=L<[4_SJU:VA,XU
M!Y>]Q+HN.1^G6Q:M>VUF>&UX.^O+V*(P[;&( I1]\3W1*6OET"C-AT>^;69R
M+=%,VN\NA<S@B.,VY:'5,EZT)>ZQB[/&YJ0X585*K =V'1 O6H7!L:TJ(_4Q
M:;DXC 7U=N ^B)=%[YY=D,CYV:>5K0FO;,_8K6;(_)I'U$F6]FMEO*EK']@O
MK&C@L)?*]F5XN^V9<W/JU<^QQ"F:=FY!]2L6;!<'@CB2SN>I_)K-N0B!;2[-
M.02CF)VB_1?8W1KJ_,,4>760.SXI<.IYL[(*GC3N[*B3FZ&,#>M+9S,J,F/C
MAJ:7H2$0;*\7W8SE>4BL:I;,HBNGD[IF97RJZ8:99>$6Z0OFF99-X]8/_(WT
M S1)N21\^H&U3'6^/M\F12%8H9(ZQH2VU@2F'N7U89+.Q^-(MV))N4TECL,,
MF%4TK=\HM.QH/,<.AA<J;W#GVYZOCJ5F);D^Q1[HTS6PVYPVPI.3%83)#=L;
M[&8T*W#RU_"];PN3\<%\[P*KJ?K7G+HN=WG+HBP,6&3,E53#FB[Z2V=D.K8V
M*-7N;FOED-AZE<YGZG&($6^,G[;EDE;!$FN^#^MZQ5T_&&=^YJ>:ZXPF_4MM
M<N.SBJL%'8-NS:]XO<,8A$7Z$+20[9JKN)PI)>+MM)7".JY$MF2M$C5ZI6G;
MYR?<(RV!Q%*.!/'YTI3[/,F*9N<AG-5WWR#+X74;XJMC_G]9'*.3:$UVJ@%<
MQ1:V:4[^^BL&-+#C=UNF(S#' R.K3M&QI2*S@RW59R]+:YX59N98C9;G5]L[
M5&[MZ^Z8TA;WMT9K[G)3E+IY;134[:[MS\:[7!(7%Z4I#]L:+=5!A6QFOS/F
M8#&@9XJKRGBV^'UWA?"O)\AM7BOI'F*3&<=,EB(6+H^P;SC29DCUJWS&W"(U
MXS,#%6;FBW<FMK+(ES^G4.:@O20_3Z&DK@[MO>/'NJ\+2CDXF\RI/1JVN?B^
M\5[(W]']5)X/6.O.K]3LGL>IH'0L;B$(INV7.8R>MUZ]MLR<I5;\20YE-^69
M.6A2*20]F;>-'I)V/ALC;9%6[B_T9U9W59M7,3!TAU)S9I95+=OV*YVVY(YS
M;'/S*T674MHUG+W(I&20V?G;'GQJ2FX4ED'+=-F\/<2>*R>-//?4--L;Y4+2
MMOC@6J^6V'5&MM5QCD>L6/V%UE9$_<U[I8CC9=C+X&Y/?1B?Z54O>'AW6&)5
M)R@HGW%% *IZU\;=IWE>$ZO2%S*+(5J:QN4[/KJ&;V?=]*'2591U6=-U%.8I
M++<H@UGLNK2GR.]$95,KU'S'4Y.M;L:+$"A)N:G-"K>??'O.*IDM42]T45LU
MK6&I>]&6>,K).KPM W]Y?8MK4%/VYS;[(O=VF5DV!HU-52*B) ^NRQM4NK@H
MU4IFI&2=NE3A57C\XUNOC^1/39,'NK)5 )#S!Q?7JEVC+O+2I@UV[S/1S#1T
MK1IV%TB:5E=:WDB!A+<VYTV<4CF6=OLF.;<:^A^ C@T>.CK4_L2L[MG%C5W*
M8'5?2W15R(GYPO'I%U?WR"W)5]XUW 8##^8SF]LY;H0^K4-K(T[BXM!#R[R_
M[.,7'KT2E2I)4!Z#]XK+,DM%\^5+O9-?1IVICQHH>0C7]N;GM[:CKMB]A<J6
M;$93A@4-S'L_5(HD7.QY+NF-4-[DK0K_ )1>A>YFYA02SY%H;IJ 7'V%T'T.
M3SZDF_29](*(_"Z-?I\[QR/E4_6R^$Y2RJ93>$19WD#D[KS]3-7(II)^6A^6
MG^E]4N#% 12CGB8ED2@E8V@WWU9;QVG#+]9^O9"H>KTM;'+<@Z#E4O7O%](T
M=5Z)U+,SP6=0":26'(#R&,M<B:%I!V"M#R]L9#UW+QHVNIJ"DZZ1S.MB'*LD
M_DR*=5FY\EU0K]^VB+JT@!C?N7&\J#-HZ?9:3=]V-++SC8D[*?ZG/L]X=JU?
M&[<,OCNY$1G%6LT@8.*N)Z.AFKR1*%$>-N#CKHS3H1"8_IVQK1K4U6RY:THF
MO92EVV=$I!QYNJ/.Q9>A@4O+.&NZY9K8]@KYM3#5.[6[":^A9M5-6WYT70T:
M>*Z0\A5GSPT5OIU)6E?IKZCRV(S6O2GQ4>RM+41,4>FJ19JVD&F)] N;P%X^
M[<Y3>Z%>;#F%;2 VK>?>JZFDA<(5S]40X22_>QF[H]@<6 R?[/4E4,+1&$NZ
M%6:\.ZYVRO\ ;G<];ZF*]@M/9_AMAT^0WK;2>*<\)^S%':<J[(YNO%_KMODF
M$J]+F/;P2J[T7KXMO(9-6[RW-"EI>4!/UVK40K+<6K.')&E,T#T;#\9%I33J
M&QK04+(/(*LZ NSGJ_[):9%TKV3%_P!VDIIN/5&SOD6CM!U1*X10O0*1T5TT
MVK8^^RG1D5L*XW)JQ&\ITZ=%J%IN=N,.BNBHJ[Q2W%=:59SA%.QO*K9D1<H<
MU3)JZ3E;U?-E]BT*V(98T2!C20QDC[9&[O?9(1(4+@N-D9>&4C[.1DD'JE@5
M<^^-/J^W:_T8KCE7,;%(JVY6KCD"J"*M3SS>,3:(QJ^:-MB8V797V_$4*V%K
M'EDH5K1LL.;"7UO8SUB_W/"TM5IE.&22GJ0M&M>M>OK3<%4!=*=Z.-IF9QLQ
M&ZR(BRXU.J]J^/U+(8X^1P^.;199$E[1$TCDB=$[QJLPI4&IC4.-"]%.X8WV
M3QM]=*.JZ^M^?657,JB%96]UG.D<D<+OZ1>WR2Q2_P"I[QK6N8Q$N:5C<V<P
M\XDU:@M!O2N>8\F>'&4:M^Z\UR3*#5"98'7G_BJNG$5Y,50*30F13"G> 83P
MQ9T07]&=:\SP!=K%&R-F)['CLJY;<XU,9^Q%/:1R*7Q"1)$R-]0')<EKF=00
M9N>$\;YY7L]VXKKKFSGB9LD&DE6MU!L+<8GDD]JUMDT'J%9%4DCK]BM6.[V/
M;]'9F<38CF])*&DQZDK)J;C<H\X_.R@! ".>+'I]GYUM9G8+:K:J>I7WLR5]
M+U!94=G5ZVZWUY#K9I6#\\VG")'9MQGN=S6')S:R)?32G9P/V+<9$0U.&2&\
MLDM*A#K='^*;H.:2$N TQ,X"BYLCF_'9-1QJ7WQTC!TM01#EYRKE:]08[G^K
MFPJF[VE,^45T6K3SN<K7-Q9]E>B0MK,)0D';A<N3>-GI#*RYWZNKDKZ"RV;Q
MOR%HX1(TVK^H<6-VZT[$ISH^!:F*#XPHQ'SD$0K9:SN3RC+5+F!T6D+VPE;N
MFUR L>Q^+?L=C73^R&E\YW26,\]9\8=*0N(6'>W5_2;$D:^78S,XX]Q2?7I=
MK0ZV_,9/(\/9![6\%HD*)JWVT^6V:_08PXA7TI\35RW!%[BQ:-J5W%YMT94_
M;2>P3*XVF2R,U];?3%N\EV#7+7!=E2&(R.45K!6'EY.B?W(U3'WQ\7+%"Q*2
MW;*L:(@FOPKR?8-!R.ZK)MAMAS7/+91UC&C"8ST9UEU0Y'1RK4LP,;%3_;76
M4F5R3)2EXGCB8WL;6S-J1E3[[:&+'0TWYQ08_&?Q6]<OUV1V76M;E>/\=BT?
M[7B)\\/N3HZ<R27HNG:^F\%@SO%N<I$E8N;N966O6U[0)ET:AY"O+IJ1A1EX
MUV*W(6A*N]6&P*@\6D.J*XZVGU@6_':VK.J4:;BV"S_H=5';4K=.A551;;&R
M9BT2F9L6CDK@3.]KS#VTO[/49^FQL?KC0\WO?B[S2/CSY XOR_-A^YX_5V)K
MM8/3^XTL^.^MO:WK,1_<:F;-AZS,1'?U1=W6^[U;Z\3TO:/TS^5HGK6?X6B)
M_@P]1!T83)":3:?&WE'D=>2OFF21^S(ZR>/VY"G"0]E6U&I# +NZ32'JR$R?
MVO\  9(I2-GS,:+4YQ^V^V-?:7Z?3?-?NXK3C(OXAH;&KY+I^58,VCFRS2:8
M?&>.SX=SBN#M%;VMUP[F"F3/V]<5ZUBL3;K;KI<? S-_[B\6PVP3%HCKUG->
M)K?)].GK6>D?C_DYU+,'-HG](SN[N1/)?9.^C'.9=UXUI/'=<NB6_P#H4U=/
M4]1S;&%)*0O>,P**75*4.Q"C4DW'T+)@K3Y:7.-:>9_NGX#=\<Y_Q[P'C-[B
MZSL:FMXYDMDI-N'X:*:D\CJ_IO:8S[FQQ>AEB])M7^KOS>W=FCJU^#RUS8LN
MU>M_2TYOK_4R?J[+?Y5B]H_A7\E.5DXNT3>:$=)ARWY0I;M#K.7'WRLV\>=Q
M_;%PT74JFN5W'E?&*#D^A.SA6+I0$(6/.JG'TZ@Y0^_*W-RMVW-VGE?[NO'^
M9T?(M7A>%V=/[[B:1Q->^GM<;RW(UW:>2[D5B\S%-_'S'*8]::3WTK3C^^M?
M8BM+<' YL=L5LN2+=N3^I^=Z4[?9K]/Y9QTFWY];_7KZWUO;R(]'2GINF+3J
MSQZ]AI)@P\Q]15=)&BS^(NCW1G2I+*LZBE$:D,35L48+?E1S,@AI"UW2'H24
MKAGWM>JI-\\IQ+X#X^\K^'>+^)^=\1\OR>67X38\LX'?P9-##J8\MK:.ARU<
M^'8KEV9Q5C+?9OBULE,ULF'TVYPY?;OJVE;>#D+[V+8UXP>[&#+68O-NGZK4
MZ3'2.OITB9CITG_3UCK$J);9BB;J9Z%HTGD[RF;,]E\T<AT+ )JX>.:VW%U2
M.W*D,=&-ND5A1;"E,@<HY(G[9(>I:DB[.3F\Q4GP:3MOH8-WM?NGT]GSGQGY
M R<3FC>XKROR/E]S5IEBF.V/R#:QY;X=//\ JO3/AP^Y2FQDQ?IS1ARS2\5F
MK%'"6C6S:D9([;X,..MICK/]*)CK:/QB9Z=8B?IUCJIVW[<M;JI/<&E^<6=]
MU_\ \RNM!Q&U-*2X(OZ0/%=5OS3FQI;#W2IY;-HNP&N=S3JT+!WV/?%[<C(C
M,83ZHTI:]9_VL;3PG]Q_QU\/Y>$M\<Z?.\E_Q;_=]C0GE(U\./=W><^RUMG'
MR&OJ[.:,?&:FAIQ%-7%GRWW]^\Y\UM?!_18]GA]OD(R?>6Q4]_VXMV=9FM<7
M=,32;1'Z[7M_JF([:^D=9]7&S.DWJTIMQ#&'WB;O=ND=70]JKSL:$P3QY6\R
M16SN8(%+HO9-;YA42/1-Z5@:5]TTNPH]F33W%-+1(WI"28H3%_.-N\4^;_'?
M$N!\^Y?C]7GLO%\MO9-WQK:V[UR[&ASVWKY]+>^ZV(R7MFR4XOE-S)&U/ZMC
M8TM'8O7'EM[=*Y^-RY\NKCO./W,=8KFBL=(MBK,6KVQTCI'?2L=OX1:T1UCU
M7+EMEL4ZO/H.2OO(?E=043:E<7!I75>,OC[N75_J^^^F*Y;ZAORV$NZA=]A*
M=%T*C9:EH*QKMDMVE,B-WT+^J]YO*<-^YG'X]\?^-<7QO&6O\A</RG&SN[F6
M:3AW^(X+=OR7$<=;I'NU[=K/;'LV].[7T.,I6UO9[:9LG#3EV\U[W_M,E+]M
M8^M<F6O9DO\ E_ICT_QM?\UKY%>W14Z;F:8R[BCLMNM>GJXYOK*G6"%\ ]+M
MM;3='S]TS4G1;I);,>54<S(X,5/S*>0-;4QM:!](B.JM:;E8Z_/UU*ZWB_W
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MU.:DO--Q1RUN >BYA$86B:Y?+I8QS6 :(8R1FSVG&;!=D[W%GI.P)W[4EO\
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M+1%NVUJ]?I,IW'Z]M31PZMYB;X\=:S,?29B(CT3/'G*8
M
M
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MJ_.I<#@D3+D:A6WF<)<6)RW!(0I*-4H-U">&ZGI]%I&FQ63"\XWTQM[M?CC
M"978//G5MZ;P#/,O>4RXHUC.)+B9:1.A*2NW]XV7;[$^PLK]KA97?,;_ #6^
MSU?R_L_Y?U7U^WSO7Y17H$*__#\\JW_GOW'_ -PWB?\ 8L!-V74%U.^<GQNE
M8UW1+X7T:TI8R2_=BI*)I=ZD\H4-#OJN?U9]-O#0=4[5M*FW&41FB9+C5)KG
MYA/H9CU 0B_\/SRK?^>_<?\ W#>)_P!BP$WN>:"ZEJZF+,@-U]SS#I:TI<ID
M1T"O-_HJEZS>*J3ND41LK(D;H+7;,WPN5ZQF1$&O!>[F29LI-/RG.]2-==0$
M']/'WY6,::XW\\-Q[[8UUQMO_P AG$VONVQC&,[>W\S,^WW9^/IZ_ !*ODGF
M+M"D9Y(Y)TCY(YYV9#W6(FLC'7DJYLY\IA#&9+N\M2\N9IY%4<?:7YT5%-:)
M0APB4[[),Z+-C<Z_,++S@+&V7P[Y*Y;8L\E4#\T5KU7"))+Y"^0^L6[BSD*5
MM]>1IT=%*QEA2&3R:)*9'(DD:;SBTA:U>88L4ZE8,.VSOMG(#U:9XJ\C4!M6
M"3.T?,5:%Y5Y&W\ASF%0O''')T&;+"9BR3]#HXLF$+BJ*51TE0:9IOE2A-T/
MU^7Z8SZ;9 7#ZFY3[DN6T"YASUY/[!Y%K_6+L[/O4L8Y>YOMYM,D"%4Z'.<M
MS+K4CKI*-5+TG6)RMDF#/I2,),;%XQDS<!&_;Q]^5?.NV-?/#<>NV<9QC;_D
M,XFS[<^GPSZ9A?IGTR F_P!6T%U-=$4KIEYU[GE_'TBBRM6?-YC&**I>XE=F
M)CVI*B3(U[/:S.Z-$8U1N))BS&[=IIMOL=DO;\377T"$/_A^>5;_ ,]^X_\
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MLON>7W3>TITG&L)ZE=:*I>%2*L]I$P)FR)&(*KB#.DK639@+P28XDX<4QF'
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MFEWB4210U/FCB^JSZ9=F@ZIFS:3M&N6_?1.EQJETS\TKT-QZ@(2?^'YY5O\
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MF,!#/_P_/*M_Y[]Q_P#<-XG_ &+ 3->.>.M%W(C)1S9WU,V7I5O/1F.W:)5
M4<NE;\21,E3\J(-I56R[5"WX71<XMCSL0DQL625A5K_VC;;;(0R_\/SRK?\
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M]^NN<!/T
M
M
M
M                                                  :==X>9[RN]
MR]E=#\G^#SG6LI)7W*KDZ0FW>B[L2H]42Z=-3VOCZO:.+91+8U!V)L6O;(N2
MLJ(].[N;PF2'.&2TZ?7;4D*?^V/OH7Z*\;_E'/W[1@'VQ]]"_17C?\HY^_:,
M ^V/OH7Z*\;_ )1S]^T8!]L??0OT5XW_ "CG[]HP#[8^^A?HKQO^4<_?M& ?
M;'WT+]%>-_RCG[]HP#[8^^A?HKQO^4<_?M& ?;'WT+]%>-_RCG[]HP#[8^^A
M?HKQO^4<_?M& ?;'WT+]%>-_RCG[]HP#[8^^A?HKQO\ E'/W[1@'VQ]]"_17
MC?\ *.?OVC /MC[Z%^BO&_Y1S]^T8!]L??0OT5XW_*.?OVC /MC[Z%^BO&_Y
M1S]^T8!]L??0OT5XW_*.?OVC /MC[Z%^BO&_Y1S]^T8!]L??0OT5XW_*.?OV
MC /MC[Z%^BO&_P"4<_?M& ?;'WT+]%>-_P HY^_:, ^V/OH7Z*\;_E'/W[1@
M'VQ]]"_17C?\HY^_:, ^V/OH7Z*\;_E'/W[1@'VQ]]"_17C?\HY^_:, ^V/O
MH7Z*\;_E'/W[1@'VQ]]"_17C?\HY^_:, ^V/OH7Z*\;_ )1S]^T8!]L??0OT
M5XW_ "CG[]HP#[8^^A?HKQO^4<_?M& ?;'WT+]%>-_RCG[]HP#[8^^A?HKQO
M^4<_?M& ?;'WT+]%>-_RCG[]HP#[8^^A?HKQO^4<_?M& ?;'WT+]%>-_RCG[
M]HP#[8^^A?HKQO\ E'/W[1@'VQ]]"_17C?\ *.?OVC /MC[Z%^BO&_Y1S]^T
M8!]L??0OT5XW_*.?OVC /MC[Z%^BO&_Y1S]^T8!]L??0OT5XW_*.?OVC /MC
M[Z%^BO&_Y1S]^T8!]L??0OT5XW_*.?OVC /MC[Z%^BO&_P"4<_?M& ?;'WT+
M]%>-_P HY^_:, ^V/OH7Z*\;_E'/W[1@'VQ]]"_17C?\HY^_:, ^V/OH7Z*\
M;_E'/W[1@'VQ]]"_17C?\HY^_:, ^V/OH7Z*\;_E'/W[1@'VQ]]"_17C?\HY
M^_:, ^V/OH7Z*\;_ )1S]^T8!]L??0OT5XW_ "CG[]HP#[8^^A?HKQO^4<_?
MM& ?;'WT+]%>-_RCG[]HP#[8^^A?HKQO^4<_?M& ?;'WT+]%>-_RCG[]HP#[
M8^^A?HKQO^4<_?M& ?;'WT+]%>-_RCG[]HP#[8^^A?HKQO\ E'/W[1@'VQ]]
M"_17C?\ *.?OVC /MC[Z%^BO&_Y1S]^T8!]L??0OT5XW_*.?OVC /MC[Z%^B
MO&_Y1S]^T8!]L??0OT5XW_*.?OVC /MC[Z%^BO&_Y1S]^T8!]L??0OT5XW_*
M.?OVC /MC[Z%^BO&_P"4<_?M& ?;'WT+]%>-_P HY^_:, ^V/OH7Z*\;_E'/
MW[1@'VQ]]"_17C?\HY^_:, ^V/OH7Z*\;_E'/W[1@'VQ]]"_17C?\HY^_:,
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MJ;_VV8 -N(
M    8Z>NO*IQ?Q//&NJ;GGLM<K6<8<JLA36%/U/9MX3R-5FA..3K;(FT>JN+
M2E3"H0G/3F:X7.GTNA_RS,DX,P69G4+?6QYHN ZJC',DQ)L:;V]'^PHW/Y9S
MTIYZIZS[R73UEJXQH)L TEBKN+O;^TK8D>]%E."18E(5HCB5!9Y19B8[70*Q
MC/E;Y-D4.I6;K?WW0)KZ#ZJCO&=6-MK<^V[5TH?[RE<>Q)V%N,B\XBK(^((D
MN;,;XP^FD:M>%!1A.3OF%[ZX"7'171](<ET_+[[Z*L9@JNI8*E3*9'+Y#LJW
M3D&+U9#<UMC<W-J9<\OS\\N2HI,A;D"=2N6J3-2B"M]]L:@(-5EYGN [5AG0
M\N9;'F\9<.6ZA?+]N*M;.INU*KN!GI9@9\OBRS&.L+ BD?E<OB!J+VX+5M9"
MK3!QQ)9GLW/(P8$AY'WOS;%HYQG*GB4O9+-WQ):_B7-:@N)2 \R4O5G07>QH
M>0^)RD63XD4NBQ>33#'#4G5.;Z%F>W;X (FS_P XW!M<5.3>+TXWV[U3B9W=
M WB<0KFJZ9Q'HB_<]2AMB%F?GRZ1:(.B&%MB!Y=2L)%;D8F(7D^\PG;;73?.
M ]RFO-%Q-=E@TK73,=?T#<NB9(KAM+R&Z.:;JIN#6%+D\4TFR:-QZ9V%$&%A
M6.KY'#RCVS74WV.6QQ9:?8PS?&H"75/=E45?=[=%<\54]OTKG/*KM&XU=;JD
MBC\57\:F4G;MG5)!D4_4HB8S(9FUH=-MG-O0GGGM>^/EJ<%[YQKD(EV-YJ?'
MO4L(?+(L*VGN,PB,]M2SQ\2&1+Z]FGT#)TM!F_9UE+"X[EM&^Y$1:&W38XQ_
M]/LOY>FV<&Y] $N)#V;SK$+IL:AI=8*.+3:I><&[K.PW"0IE+1!XQ0[G)I1$
MRYNY3I;H5&24Z9UAKAE05E1\TA.3\[?&"]M=LA%CFWS->/KJNWXM1]56W)4T
M[LEK=WVE];*J&V:ACM^L3!JJ->G:C919D-B['9B5N2HS#]M&XXP\Q-IL<67N
M7H9MH&4L
M   &F=X@=]\?>;_.05C??!6\:=#-R\;9QIL879=8:E[[:>OMVWTU-VQC.?CC
M&V?3\.0&YB       #4=^ZM_W_YD_P#4:F_]MEX#;B
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MCCUOP-WK6>I#HA*WJ'KSG6'OG_V2;DB]>QFGHC-_Q52$PH_3\0S4!?D
M                                                 :9?B"_W.?G&
M_P +N_\ F95@#<T       !J._=6_P"__,G_ *C4W_MLO ;<0
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M/;\?7\'H X84$9WT*P>3DPS3YA9>#-,[F%YQG.-]-/=[MM,XQGXX^ #]@
M                                          !IE^(+_<Y^<;_"[O\
MYF58 W-        :COW5O^__ #)_ZC4W_MLO ;<0
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M93+DFZ1L4M>BI%IJEU2IPEK%.5YU:E*>):A;!6](6GS/8_D^Z>3O$:=J4O\
MY396/DR35HZ'-53IX9)[/GUILW+;DN*<$\<,?WI,<JC#EHA,++SIMG<.G:M&
MZ4=Y9T)=2\Z6/T@[H>TN=&ZOZ]LF@>QJ<OR@Z=@T=CD'8GSD;M>J98ZT&_\
M#]>,!:@Q<R2[=F1J"TF4BU*?KKNI.#>K
M                  &F7X@O]SGYQO\ "[O_ )F58 W-        :COW5O\
MO_S)_P"HU-_[;+P&W$
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MJYCBD+>4K,VF;_3.BQ(=N9L65KKDPTO78,KX
M                        #3+\07^YS\XW^%W?_,RK &YH       #4=^Z
MM_W_ .9/_4:F_P#;9> VX@
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MO:01T]Z:'!J)?V%7!JTT2O;*:N3D:.K0JW*VP6I(R83OG7.-=L^F0&=(
M                                            !IE^(+_<Y^<;_"[O
M_F95@#<T       !J._=6_[_ /,G_J-3?^VR\!MQ
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M58 W-        :COW5O^_P#S)_ZC4W_MLO ;<0
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M46%9<&^0U%IDC/+YC.,:35Y<_H"2C<;/&A3J24;H2K++/+,+U";(
M                            #3+\07^YS\XW^%W?_,RK &YH       #
M4=^ZM_W_ .9/_4:F_P#;9> VX@
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M_HS^#_W?@ ?0 !\],?U8_P#T_A_]X#Z  /GIC^H!]
M                      :9?B"_W.?G&_PN[_YF58 W-        :COW5O^
M_P#S)_ZC4W_MLO ;<0
M
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M*:TKT^91])2IJ:WQDJASV96M?HUORAJ>DAQIJC)2)+@_7!YY>WKC 23
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M9:\B3(WY(K)GU /;U#7R#JOMY*CSN5!GY6X$:91:;-YIR@\XDPW)VYFX7V
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M2BT[HHQ'NI5%$SV34?&VVPVEC2FF+2T3ELU_*UT.**UU"V,;<'Z(<8>2Z?\
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M!+E=:"\J'1#"Z6<KN6'>2G6A9=-R9??#X37G!2I[Y$?NCHS7\(ADT8Y DJM
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MSV3+(U+XZV)7AC5/R1*[98UZ35446=KOK@)T@     #3+\07^YS\XW^%W?\
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M2D*"T>S86C8WV?-"8W0P_0_;==IG33?7&^VH7+SKKG\.,9],^OQQC/Q_K_\
M6 MJVV[6SW;$MHMNE"!;:\"A,)LJ6PS4A=]H,<)L5WF3#")$H4&H]&PQ*_O%
M?/)!6I1YAVFR#?)FFFNQ>=P^PNW:UL666O!H9*4+_+*/EK1 [694R=>4HALL
M?H1&+':&1P,5HTZ92>NA$S;'#79-N>5@I9KKMM@S&^FH7']NGQQ[=?7^G'IC
M/P]?7\']7K@!1<KL2 05S@K+,9;'8T\6?+?S"KQK>7)*A<)M,\1V02[:,1M(
M?OJ>[O)<7BSFX;$$Z[;Z(T)YN<8T+VS@*T]I?KC;TUQGTSKC;X>OIG/QUQG\
M/IG/] "V[Y;U;QJT:^I5[E"!OM"THY/I?7T0-(7[+Y+'*N-B)$_=D1Y*,UN(
M)C1L]:-3M3SBC-_KM/EZ[^F_M"Y6<8S^'&,X^./C\?P_#. %"6=8L#IVMYY;
M5G/J&)UO5\.D=@3N3KR%2A!&X=#FA7()&^JT[>E6KCDS2T-YQ^^I!)IN==,X
MTTVV],9"J6=S;'YJ;'YH/*6M;VVH75M7%:;ZZ+6UP2EK$*G7!NA9N"STQVN^
MN-]<;8QGXXQD!0UIV[6M)L#3*;1E""(,$@G5>UFU.;@G7J"5\ZM69,M>5Y'-
M=&Y&M/PKD\RD2) 1OOKJ268HUR;N67C;? ?)S;E:UI):JBLWDS?'I-=LU65K
M5;:J3KC5,QFJ*&2NQED<;SD:-22F4DPV#.KAG93N01DM%MC&^3,Z:;!<O;&F
MV<>[&NV=<^[7UQC.=<X^'NU]?CC./7\. %&*;&@*.PV>IU4OCQ%G2"'R"?LL
M$,<TN)4Y0>*/$>C\CE:5F^9]<9'V9]EK:D/5>SY.BA<47Z^[?& $<NHN_..>
M+UL2:NGKZAE3NTZ3.3C&V9X+?'=X5,+*802^2UP:(NT/KBPP9B.5%Z+WYP*2
MLR+??7!ZDO.<8 7VE%QU)"ZE=+YE=BPICI5DA&;)<K37R!KT@:: X:M'TN7X
MDNJC=J/8%#09HH(4EF;EGE;ZY+SM[]?4(X5SY&N';5HJT.EH5T;7JJDZ4V4E
MV[-GPQWA>M;&IT"-T+(FL=FK3'I9'CG5N<4QS=HI0%[.I:DK*/!_S-/<%T.9
M^L>=>PH.Y6/S;9[%9\49)&MB$@4MJ-Z97B,2IO3(UZJ.RN*2EJ89;%7G5N<4
MRK1.XH4QIJ122>7C8HW3?8(J3?S&>-2M+(FU3SSJ".Q28US.7"M["V>();"2
M'0J:-"TAN=VF665F YK=A+:%BDO56K5.Q:)+C?&QIVFOQ 2IB?6O.$XZ)G7)
MT2M:./G1%:U_'+3FU8HBW7+PS5Y+,-&T>E>KB:VEL+JU.&K^ASZHUBC<G"PG
MYFNGS-/4/VI;JWGCHJ97G7]*6>PV%+N;+!,JN\F=E3/!>]?V$3];J?&'-6XM
MB%O<%Y!C8H+,V0FJB2S2-R]M\;ZYUP%G+\\F/!G+ED%U#?'3E;5U8A:)I<WN
M-."AV<C(.T/VNN[(]V@X1YI=VBIV%X)VP8E7250U)%!/_$T,VTQ[@'5Z'\G'
M#/*4Y9*UO.]443FTC@+5:3,PLL#M*PS5E>OKJ\,C-+OJJT@\P;D[,Z.D?6%$
M&FG%_-RGVSKC.OIG(>=8WE/X!JNJ*FO:8='Q8RG+Q;)0\U=9<.CD^LR(25MA
M64.DN5&/-;1&6)H_I&S7#0M9JYY1;ISM32]\8W(.U+"ZO+';W+_:S7+'CF:R
MM[*9X.='R)(OS!K&AB5)M*$:UPCYB+>P8A%-7M*Y(FXTW0Y!]23KKKC.VVOO
MT]P2N]-/3'PU],?]7\'IC^GUQ_ZP'WTU_#Z8]?Z_3X_^_P##^$!'><=6\[5W
M?]/\L3RSX_'+[OUIEC_3M;.B=VPZ3QM@B!2ZRE0T+RVPYA*/:4",TWY"A60H
M.U*V^3H9G7. ')EZKYXD72TOX\9+.8'+I6 5PV6Y,:G2IG?=]CM=O*]J;&V2
M."[+9JP%EJU;ZBQA-JLV68+5E&;%8+WUVR$A/87CX^S3&<9VVQ^+CX;9QZ;;
M?@_#G&?3.0#3&FN,:Z8TUU^.<:Z8QC'QSZYSC&/A\<Y]0%K"[IJ,VZ5'/*><
MQL^[TU<8MY?6R95@^4-];?G$FB2>8.J0@O?5M:5LB582)=E&Y9BHS0SY.N^I
M)NV@6(I;R#<5]%W+-.?*3Z$@%C6W D\A5O\ $F QUWT4I(@^I8W+U<4?UC4D
MBT_21"1K24+L:PK7(ML5FZ%*<E;[8QD)F@       TR_$%_N<_.-_A=W_P S
M*L ;F@       -1W[JW_ '_YD_\ 4:F_]MEX#;B      &N_YM3(]I9//;G+
M+^K:#LD.JN^)'I0725@]'<VT%>2X\V#E;/<(ZEH9U;2(KU16[>W'%19E<$$H
M4FHWU4L1->AI65980 E\EL%MF_>-XTPW]"U#UA>'A#\=UD02O)Y;-BR_HINC
M&\EN9JZ<4Q=@>7WTFURTY6C8W&[+VQF^TVB3*?JR$B1S>EQ2P*WL&:1UA8^R
M&KQTVW:LO\=*6O/'*KOVP:LMRX+3WKIPF'4;BV=HK*2LI7)9-/&*=8XDRD=)
MUI'51[DRG[:+CM$CN89ON%%]7DDR53S=!/#!:,LD$@9N]IH;1MBVE-'*W.7X
MS8KYXO\ I_:;Q#E>U):NG*Q=DMM;S#%^7$]XBT=L1[+WW*^5]H(]0N-'J\YS
M[5OWF-0TJ.BEU91#PQ=9GF-4[NZYFB\(_>,$Z:IN)S>+WW/6>6LL[D=M5E9.
MKKE:0M6[)D\A1Z+4I.NJ=#N4%GU=OH9]0$!G/>=ZW)&YBK\(/&=J<"/K;;%I
M5_(['[#DE<SY9>DPKU- 7MJS:W6Y5J%0 E,UGD.+QLW+2_E(#4:Y?N<';?)'
M.R>NYJH[>?'NKZ2G5D^+Y%Y*Y&S2605I&6E_/\:=NN47C=CS&#.[89$Z6>.M
M2VE"^F_6$,V3<(DBY3HC/WT."Q4;?C4-8+6BKK0:&?Q^3/S7]U)+/M?H6Q[W
M:ZH>6A/1L'.YD;;PN"(S"+VX?3+]-BE)32O=7?['=%J)@T<5*@DPGZ@,@//L
M%E-SV'XNJ'MN^+2N:A)7"O*9.&XR&3OI>JXQ-X55]P\TG\S$*9/))RAM^UHA
M4J&0J]8/*WEQ-4/C04C<"S3RC/FG!;21EE2C@NNG&R^A(90]GRGRJ]TRWH]J
MOS-R0OEZVK;BET]&1)OH;IVYZ3D4->*.BZ"$M4<51!2O=3F=8KCK2D^C=2\D
MIM@D?4-E+IQ#O!)/H+#)M!;$/[ Z1J=ICLMMF97R?)N6DU,=1I;8ED<MNQVF
M/3^Q*'?-*^A\@A[H^)42S9J+8<Y*-WU3Y,"0WENFL\9;MY[A+!>US4%")YQ1
MY4]9M.:<:)]-G:(NC36O/B&&6F75L VW=Y]):H.DBYR:]4Y7VD@UW5'(CTIG
MO/T#&_SO,$$RIR^^$8-O7\U0=(VIQUSPHO7EWIJ];XY0LF(VPEL*2=*$0%KO
M)QE;Y3-X1_E2J9 X3=D;9#(DQAKJS'JU^%IN=#0HOL.]7'?O.5RROGUV@=H5
M'Y.^&J53M\]Z9N,N^8Y3ID[H>"38FGN1JY@+)2,+X@M"*3!Q,.D4O>'8F1+7
M1=L=MHX;M:-.%676U6H1R_TWT:W3ZR</#WYC[[YPZ3LB>7!T$9"J[\?$.[6G
MC9B*+FN"3MJ=*\I*-N3(Q(GATC1*-U;(JYN^NJPAO4+,X#+_ .'<A\351?J=
M%=4/NFG".@7$JDU58[W))*;A+'I X-^>D-I&V+NDTNDMKU:EL'+DJ3*T*]4R
M-+HJ<&E";DA#J44&'WC)]OF3=N5Z]6+T3#HMV+IW1T:Q]$4TWNW44XO]XHQI
MD]K)&RO[%IXR?+>?8!RV14^D4=(7+RV5.S(3RFLU"J.<G!7A2'8XGBLH=67P
M]2]]L;HB4S+N*@O(A7O5CS)+ZO!\=+1B[%7<GDE?LZS"V;&_FFN@#L07I&U[
M)HV.S5IG;5.IQN<=L8&-"0Z%RKQ?4533-/;-=Z@A/A.@EDS^!,-R6KO&XM?=
M?^0?GI!;"J7MS5,<?9$BK% YOJ-:UK?83&4!.R?1.D3HR="0R!==R*1-M_\
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M.%H6J[ KCE>->,ENKOE.?R.[F*G.5?'1,=:\C<VE]C:3OQ_T/U? 9V\VDU5
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M*21YW3Z*VQX:5I?_  U2%:F,QN7OCX;:Y 5J      -,OQ!?[G/SC?X7=_\
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M8]<?$!\T1(RU)RTM(F+6*--"U"O0@K52>67C&"]#C]=,&FZ%XQCVXVSG&/Z
M%,P*!Q.L(@QP.#,Y3#%8XE,2-+64H6+,DZ'J3UJHX]:X*%;@O6KERHT]0H4&
MFGJ#S=S#-]M]MMLA4V$:3'RO1*FQ\DXQ03Z$%8^2H.]^33ROQ?\ AG&Y-V]V
MV/3;;W9]<_'(#[HD2E[:;EID^FY>3]B]M"2]=M-E6^#%.VFVNN,ZY4&8QMOG
M'_7S\<^N0'/0@DLPT[0DK0X_V?/-T+TU,.^5K["OFF8QC8SY>GPU]<Y],?#
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M\9QG&,X^.,_'&?\ HR
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M4)--]S=$I^3=-LFIM##-ML%[>NN-MLYQCUSD!W@
M
M               &F7X@O]SGYQO\+N_^9E6 -S0       &H[]U;_O\ \R?^
MHU-_[;+P&W$
M
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MD7U7HOUS,$M6KI(9#T<Z.;/;[]8\HE!6R'4_U],J-<Z^@"ZX!ZXS_3^#\/\
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M(D\A43%HX4I2NZV0)E!3(V%GIWYR+^2XO9!VB7!A3NO*S[3E.N<'&Z_#;;.
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M*<PFPJ2,Y<42KS&G*"Q+W;Y$X.Q/IN4H5MZ<W/XVN-= LCXV/_[M_!W\?_\
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MRU&*XNR2PR"0^2V94%2NDZ,D,6:LZ(YW'Y$IU.V-9'?*IDP<M5J,)/J5&QV
MSM>87J3]R'CMK23R"16S&W._;4YHJ!1,ZDN=JY@(87.RW%*\.3E:?1RF(3 [
MGZE',AF4(9')&I&4ZH4BS&B(].89@W0->"J.V^GM/'?TZRD=7S8RG(1YRJGY
MZM/H*"='V'=;QSWXZK*/A#C,)+6O6D_2M-NN]88=%NB1GG2\DM2>V.1J@CY1
M1F,E!-2[^CJG9>?^4X;SAY$.J)EX\9AY995176_84TO"?MKQ5\#2QAT=F6CX
M5V<XI8_,%'-;M,,)4FD]*D3MGV&?(_.4K3;!6H?I:W1U=+X)XGJ_B7D'ZT4^
M)ZVK\ZVB717=-AVI.Z?L)VD=:(W-?SS2DJZRRQUI.&.G7R;E.#6BD^7;.TA0
M-6I9KR?DG<W0(O5+=O772BKQI<TN?9'6C+S7?/D1\FG/]8= Q"Q7N%7/T_PA
M35;1N3T=-'JRLH"GF3N"IP1.K6BE>VF70P@O=22=HH]#0$=?+[9"9TKWS=5=
MTSV+T'"[QI.2\YT]Q3R$XW3+$L+LSEE*CK.1E6$;3QA:]NO-5-"&QT?I1,5V
M%Z]F7MI1IRQMQG!1P71ZV\@TT1=WQV0U#T);E32"F_)QQOR[+J]L?MZ4,#DN
MJM,RP^-6JD@?CPBT':*NUY-E6KUJK46+-'1R=USJMT*3G8P;H60%<7S>74^D
M'\B'6R3L7JEJGG'_ )]4O-%$PMIN21-].L-*/EIU6T/L!DM8I\ZQNP(ZO:Y^
M<04E?"UY+:2C)+1:IB]U>BD)EPGI&'O7DVZ01=L]W]2\^](U_P"4>MZ*XWY.
MJ6R9KI%;&YI=Z_95E5I7GEYC9YE&)Q5%ZG+U:F6S18S'&M1Q9.?M1FSOKG8(
M>\$];]O6#Y J6.M3JV$0[H.5][=+U;T9RU/.M;VE4O=J2BN\D3(ZF9> F6@9
M'45",E:1U"D>XC8'YT(RY#OKN6K=#MU&Y)(9)/._TQU=Q9;U23*B)[:&6#N7
MGJU_'[ X>R/[GI$*N[+G$T@CGSS>3.VZK4Z5EG9\??Y*DRXD?]H^2T$8]NV=
M<9P&(Y/V-Y%WSE7R2_GCT3?,;G7B%X@G/)5D3IOFTG8]K:[,?NMIDV-]ZX<2
M7+4Z1O4?YQK9G^A<%&3%B<Z1GG?-SL9KOL%LKPCT>C[U]YE/E%[64]6G-.!>
M(K'CM>3ZV3G(VTF"PJ&K>8V78&T)<=B5DU;:7E3NB8V)Q*T,(B;<\[-^-L?5
M8]0S?^.%19-!>5F+<I(+^OZTJ5M+PM4)U6_Q2\K8D]K)66[VRV6>J]Y%7I<F
M5*2:W97.)F&:J&9FT2-.3-M?81IH2GT*#')W1"H="O(9]XM-?[ML9),I?X?'
M>9UQ5DLMH\IHLU$]\_VH7-$++ 5QB<^;0^H$[7E0U)TFIQ$9-//-]=<[Y] M
ML[6/V)PO7=1-/'E]]+3^1W3]W(0]&F5_8-C2"X&&(6M \5*B36+2,!DYB]EK
M=RKFLI$Z_0MC$F);C"&\C!B-2;IG)@93O K=5LV#?%ZQ;7K:M>A:*)YMY\G:
MF#1_LF^^[9?7MWR313]N3!?=-M4)6;1"LVHT?4*7R )'E<;%7I%@LM"D)-VT
MT#'OUQ8J&#>;/RYM;AWQQ;PPFF5'\4LYROL.BHM>">SR,\^N*4]%7:&4SJ(I
MV57%BG'.SEC1*[ZK<.";4Q-M@O&AH45R?;J9GX_\$5$WE;ER\!^.&<55V#BT
M;;BMX3>A$-LWU7,OE!]8YE'2"8F RRJJWM_52[SB-LIJQE)<OJ2V_7*PI$3G
M(=5^[XM^5\6<-5M?U]WPUJ[ >?(#)J/Z)LSL>7^/R#7SSE2*TV*\^V->EO5Y
M6KM>-K6XK:5Y*V(Q9CV:?SR4ZIE3KLMU6D;Y"[7'=M=-]Y/'@GI>V.R^J(U#
MKWX:ZKG'0JRG[E?JZFEM2WGJXBF:(ZS&;,6V'\M^;5482I79>2:2\+"2E210
MH]JQ7@P(;7#<W[X7"D'OHKKJ[G_R D_>%ZFB=H\6R:TGY3 *=I>M[]/8*V-8
M.=-DF\9KV%,#$YLV6F7I="LO:QZ/3F.*\TS))0;,GFYMN<5ZIX!AK]<M@\T\
M8W'UFC@W:_0U;3)TJQXA4&TB;@YUM$7^YV3=&\TU!;.L,@EN=Y"F7M.Z8G34
MK9<06=O[PUTGU-,^II]P,UN74/3UF<U5WY[9[SAQ+T!M;TAWE=A\[Z5T;*/S
MV9;.6I3GFU'FM)\T+F&-6&>>N4J&PU8E+4G::9SH&>+[Q5)H' ZV\6LQL]WC
MT>K*'>9'BN1V ^RTU&1%62$,3=:J^2NLD.78^@)86]G3FFJ]CL?*U(UVSM^+
MZ@,6O4%]5Y*NH?+5VCXN)VV(*7K7PD/L2N/H7G$W9@@#GV8DM,R34^:PS*-$
MI65\M.#4VC/^8N0&84($1A9!AF=O334+MTC8/8-\]-]T3%IZ-Z9F$IXF\:?#
M/2/,_/C!9KXDK*Q.G;9X9>I#E59$-1G)MK&02.=M&BHYB4J-&QS<UVQZDHTW
M!>=0B/X_.Q.['*O;@G-.]:Q.]KB<?$?>MYSZA#.LKT[$M_3K9F(RKB%KKZPF
MU"1:N.2+"CLIV5,2ZK$,I^E.(+3[)$*_VE*#P[%O2WFB]/#GW"U4SY'>SNIK
MN4^-SFOI'I&NW^\K%N*LX?91CDB>9PN<Y>_,+REKN4R9Z4+4,HK=.^-J1.U-
MVFQC*5E-N>4%W[ NVN44LY]I^^/)%?\ 1/!<2\01ES<FW] >KY'",7]U>V2%
MT:['V=N@(2[-^;LL2E4!29"Q5X>M5E;:E%%X;5.=]BS0K_CFQ>W.T^S>!:RZ
M\Z.ZBI?*+POUWVW;%:5G,'NKMK#NZ#]=2Z&0:9V9$XTB;UNQ<VKI4V.,B84I
M"+1Z_P"$C4%_3Z_( 6X\1?1TDFO=M5T1<_4EG=KOW0U9=?Z3>U::[3E]NT!9
M+8TO#DXJ#NI^!+EKR/SW@U[BC.>4Q1HEG(C;<N6':D%%KDIFVX#/3Y H:V^/
MWPH].0KD-PD=*MW-'(TN:Z4=HO)'K25P?\VVK.6ES;Y8I6'OQCZ4=OL=NN,/
MW5&G[[&;;YVVSD!KF=<3/IGG9[XFK>4=HW ST+?_  7/^QY7?O3GD'N3E-NE
M?;DI88NH>VMDNVL:VLQTW0U/&]43_#J<0M"&-NAZY07@M6;MJE."ZUG]5RY[
ME7)<=\G'D0MOG'G??PR%]#0[HSEBTK3Y^*Z)[%1V4F8'R;QGY<0KR8VO8S-5
M1C0\MD =(R5HJ7N1V^&9409[<A?3O;HED<NKRH-U+WETQR9Q_'_%"W] <9V@
MP6G+^5I!T3T8?L;B33>;/,<;*[66%>D58M6@]/62U(5KNH7;;88?51L3L$ I
M+T+WM>]8=,RGHGI+JNG;/H+P*TGV<WP"M;8F=&IT?3B%QG_V%:<QC4(41I4G
M=Y-&VU(N>8]OJG:5:A=G58AWV2)-4P5#;7175W.S;T_F&]@=1OKK9WW<.E?(
M ^/DYNB62E='NKI7>D-B[W9-7)EBK1IJ!,IC[VH2:-$93M;263MKC5/ZZ:9U
M#TKT1WQ%Y=Y (JA[D[RV9ZK\(%=^1N/Z8ZPM=$KWZ[4L[Z8=/=7)L?$+@QP\
MY2@W-WAC2:WP_?<_&-FW.J='JG"U?4?<O<DFL8QPGG8K+S*O8/'3XYKEY&G-
MB]8W!S2R2NS+@K.%22ZK;C=!4W1ES-G=TD=+86K8\]11T1:E-#3MC=,DVUV-
M5)PE;V_:/5,_L7SS/#UUOTI62[@?DO@CH"B830MU3FMJXB-V3GGK$OG3KHUH
MB&1[D,.=I#%S?<QNNFC<JT<3SU2'ZW!)R<+/>0+H^16RO[I8.T^Q;IHLMO\
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M)9&#M]_E:9SKKZ8SZ /5                     :9?B"_W.?G&_P +N_\
MF95@#<T       !J._=6_P"__,G_ *C4W_MLO ;<0
M
M                                               TR_$%_N<_.-_A
M=W_S,JP!N:        U'?NK?]_\ F3_U&IO_ &V7@-N(
M
M                                                  :9?B"_W.?G
M&_PN[_YF58 W-        :COW5O^_P#S)_ZC4W_MLO ;<0
M
M                                                    TR_$%_N<
M_.-_A=W_ ,S*L ;F@       -1W[JW_?_F3_ -1J;_VV7@-N(
M
M                                                       :9?B"
M_P!SGYQO\+N_^9E6 -S0       &H[]U;_O_ ,R?^HU-_P"VR\!MQ
M
M                                                           #
M3+\07^YS\XW^%W?_ #,JP!N:        U'?NK?\ ?_F3_P!1J;_VV7@-N(
M
M
M    :9?B"_W.?G&_PN[_ .9E6 -S0       &H[]U;_O_P R?^HU-_[;+P&W
M$
M
M       -,OQ!?[G/SC?X7=_\S*L ;F@       -1W[JW_?\ YD_]1J;_ -ME
MX#;B
M
M          &F7X@O]SGYQO\ "[O_ )F58 W-        :COW5O\ O_S)_P"H
MU-_[;+P&W$
M
M                -,OQ!?[G/SC?X7=_\S*L ;F@       -1W[JW_?_ )D_
M]1J;_P!MEX#;B
M
M                   &F7X@O]SGYQO\+N_^9E6 -S0       &H[]U;_O\
M\R?^HU-_[;+P&W$
M
M                     -,OQ!?[G/SC?X7=_P#,RK &YH     \.3R1FAT;
MD$ND2K9#'XNR.LB?%NB56NW1M#(@4.;DJT1-Y"I>LW(1)=]L%$%&'&9Q[=--
MMLXQD(U5]V?3-ES]@KJ/);00/4A4O3"F63"H[#@K0WV%'8Z9-'JIG]1,&!E5
ML%FH8(08^9;%9!7S&K3YVAFWNTUV#7.^ZM_W_P"9/_4:F_\ ;9> VX@
M
M
M!IE^(+_<Y^<;_"[O_F95@#<T     4+:#<E>*TL-I70HVR43I!I:W*ZZ(5($
M)T^2K8^X)E$+*6NJUM:T9LJ)-RAU-4J"$Y>3\;&&::8SM@( <PTGABL6$3<S
MCR=T\BPTO,ETD$UZG?[4/:IA*(^>C73"60*121[7OER/+"OS'ELD<,J7U.U:
MX0;JOHRM"M0PK?=6_P"__,G_ *C4W_MLO ;<0
M
M                                           TR_$%_N<_.-_A=W_S
M,JP!N:     /!E3B]M$8D3K&H_F6R)L8G=P8(KAT2,>9*](FY2I:H_AZ7Z&(
M6?+RO*+3?5':[%)_F_,WQG77. $>:TE_14]?(4Y6ISI#:QCFJ$V1?:3=T(\R
MV41UU<(XJ3)VAVA!-10]M<U&-74U*JT-<C"$AV/G%X-W++VP&N#]U;_O_P R
M?^HU-_[;+P&W$
M
M                   -,OQ!?[G/SC?X7=_\S*L ;F@    "DI\XRAG@TR=H
M.R$R6:-<4D3C$8XH/+3)Y!)T+.L5,#(>I-4HBDY#L[%$I]]]CB===3,YSOIC
M\; 8^:1L:[)G<57IG*0V5:T<,Q)G6S2;+Y F_-"2DG+\R'C5D<H=)I02R)WM
M2X.:PEF-CIADI7&)G<QQPX$D(_::&%#[JW_?_F3_ -1J;_VV7@-N(
M
M                                                           :
M9?B"_P!SGYQO\+N_^9E6 -S0    !X4H6OS;&I"XQ5C32>3H&-V6QR-K7G6.
MHY"_)6]0>SL:N0;H'31B3.S@66G,693*<)=#,FY*,]OLR$=J[EE^2U\KU?<=
M+T% VI>E4O328S= 22P+"CTB4Q9=@UM:(VX\^0EB7N:9O7*TCB<C?<ZDI<G[
MEY4%Y]-@UP_NK?\ ?_F3_P!1J;_VV7@-N(
M
M                                        :9?B"_W.?G&_PN[_ .9E
M6 -S0    !1%F0W:Q:WL&OM'E;'=IW")7#=9 VY/PXL6TG85[)AY093*V]3A
M:UY7?/*^6>1O[],>TS3/IM@(2<W<)K*!M(ZQCY=3LB(.^OU1L\?YW,A2N$HE
M<<0,7YN5$YJK=F+944,6+D1CHYM3&V)B'=R7*SU.=C#O?J&"_P"ZM_W_ .9/
M_4:F_P#;9> VX@
M
M                   !IE^(+_<Y^<;_  N[_P"9E6 -S0       &H[]U;_
M +_\R?\ J-3?^VR\!MQ
M
M                         #3+\07^YS\XW^%W?_,RK &YH     HRQUTN
M;*]G3C $!#K.T$.DRR%MBE,6L3N,L2LBX^.H3TASLP$JRE;N627L5NO0Z&8V
M]N5!&,Y-U"&V\YZJJJQ>?XE9KC&I_4TKG2Q%.K_;8Y'JYU8F]RKB2M<-@5GP
MUSE+KAFE,OO%WCR-@=(X8:E7[[Y;E:9(=DDYR# U]U<QG$@\RF,XSC./(W.,
M9QG\.,X6S#&<9_Z< -N$
M
M                          :9?B"_W.?G&_PN[_YF58 W-     'AR9Q=
MFB./[JPL!\K?&UE=%[-%TK@WM*F2NR-"H4MS F=7<Y,TMA[RL+T3Z*%1A:8C
M8S&YNVNFNV<!C@A%\SSL27YHZ9T2?3S=$U-66M8&5-LQIXLJN)56UN,-@Q6'
MRZO<QI*K3I98[5]H06O)--0K6\W=6WJ5*?)9^0PM?=7MO?(O,MOG'IG?R.3G
M;.,?T>Y=,,^G_P 0&W
M
M                         -,OQ!?[G/SC?X7=_P#,RK &YH     H.TUS
MHUUE8CHR/3+&WIL@TL<6B0R1S*98ZQ.:%A7J4+P_O)Z%S):&1M4E:G*U6Z91
MJG(TW,R49C7V9#&ESO9YEM] Q2P$/3$/43V6RF?J9]0,6NESL:OB*,::^6,T
M2B4/9WBJ*[PU69#K*0-K^XDG(6Z0)T3FY;JC5"(],5J&(;[JW_?_ )D_]1J;
M_P!MEX#;B
M
M               &F7X@O]SGYQO\+N_^9E6 -S0    !:^[D1SE3-MMR=C<Y
M,>X5E/$1,<93U29X?S545=2"V9I4H4ZM<G<W/??!"?<DHP[0W?7.FFVV,:Y#
M&=4-[P*YNN8\V06*UVX1]OO6T9?C6([S1MMQDES%SAO %/0-QMZEK*C)L/G4
M=>OS43HCRT:UO<C&S4T\Y;JN0MX8GONK?]_^9/\ U&IO_;9> VX@
M
M                                                         !IE
M^(+_ '.?G&_PN[_YF58 W-     %N+B4Y1U):*O6:%UOE+74W48L0THP\J!9
M(C+H;^>AI!1I!IQ46]GUVVNF^FVV"/3&V,Y]0&(OCV=P6:]"U.FKQ_KV%K=(
M5(9G+/W:W?U/=B/HZ/.L9<6QO4NVUP5E HAJD;GPU,^)I"O6.\AS]F:(DV^$
M:L\PP,;'W5O^_P#S)_ZC4W_MLO ;<0
M
M                                    TR_$%_N<_.-_A=W_ ,S*L ;F
M@    "DYX_NL4@\RE#%'%DP>XU%)$_L\2;]SM%\H=6=G6.#?'4.Z9&XJ-5CV
MK3Z)BLEIS]\;FXSJ7OGTUR&+7E.=8*Z!93(8[U19+?<3&\:V8PTO!+[KYHYS
M5,Z!^FZ)U>HU8LRF,+C>9M)3\H7-+ALACVYNKFD7;(3L:JC,AB3^ZM_W_P"9
M/_4:F_\ ;9> VX@
M
M                    !IE^(+_<Y^<;_"[O_F95@#<T     6ZN#<LNI;1W
M.F)]=DZ5W-MS; 2DK%"J#%ZQISSO,$R=N4)' ]1&=<?6Z:$&E';;$8QIOKMG
M&V Q,\LMSFW]"TON_P!)D\H*#&V;I$+NRM%S%%=>*LP1U4JFB4;S-(V$1U<R
MD)]I(G1S'9PF9N8[MLFWU1ZJMM@QD?=6_P"__,G_ *C4W_MLO ;<0
M
M                                                           T
MR_$%_N<_.-_A=W_S,JP!N:     *!M8IP/JZR"&F'MUA.IT!F)39 7C";9HF
M[@9'7'1%$'35;N4CRW253MJB/P;MJ7DH_;W9QKZY 8G>2X,OC][U8N8W"W;D
M;4[5*D4H*NNB^IZQ;^6TIT'5F-^]4NW1$Z?V5I/>W+5,Q*&$G1ZDBA$^'*]7
M0IK3F)SPQ>_=6_[_ /,G_J-3?^VR\!MQ
M
M                                      #3+\07^YS\XW^%W?\ S,JP
M!N:        U'?NK?]_^9/\ U&IO_;9> VX@
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M_-FAEF[!&G63UW(]R-\-LC;"5C$X9US].K- 3%
M                 !IE^(+_ '.?G&_PN[_YF58 W-        :COW5O^_\
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M)0W*%"I=%T+VX[MZI0L4;93YV-QGW[Y*SG 6HB?BT[OK_6S8VAK.N9,Q7_\
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M>+/6ARIG3'[.&CE]1@I/G0SYNX3)Z/\ %GW?")5Y (GRQ5%&6[6/D<\?//\
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M4%ADP9&>#U/SX>X,&CA'V+?&CNQJCC2-2LD';;:!L5@
M                      TR_$%_N<_.-_A=W_S,JP!N:        U'?NK?]
M_P#F3_U&IO\ VV7@-N(
M                      'G?8[3]I9>OLMN^V,D?2Y=OHDWVEE-_P#PV5_R
MOJOD?_L>_P!O_0 ]$
M                 !IE^(+_ '.?G&_PN[_YF58 W-        :CGW5K;7\X
M?,IK[L>['D9FNV=?7'NQC9=,<:YSC\.,;9USZ?U^F0&W&
M
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M+LZD1AA=)&;O(I-DZ12)P<7)[7%(U+JJ4:>Y,3JGT]P9V
M
M
M
M
M
M
A                                         ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
